Browse by Track

(M0930-06-36) Elements of Robust Modified Oligonucleotide Extraction through SPE

(T0930-06-36) scRNA-seq - A Potential ELISpot Alternative?

(T0930-06-37) Highly Sensitive Analysis Using EVOSEP-LC/MS Assay for Targeted PD-L1 and PD1 Expression Level for Predicting Response to Immune Checkpoint Inhibitors

(T0930-06-38) Quantitative Analysis of GalNAc-siRNA Conjugates in Tissue Homogenate Using Two-Dimensional Liquid Chromatography Coupled with Tandem Mass Spectrometry

(M0930-06-39) Enhanced Pharmacokinetic Bioanalysis of Antibody-Drug Conjugates Using Hybrid Immunoaffinity Capture and Microflow LC-MS/MS

(T0930-06-39) Quantitative Characterization of Oligonucleotide Transport Vehicle (OTV) In Vivo Distribution and Pharmacokinetics using Ultra-sensitive, Plate-Based Bioanalytical Methods

(M0930-06-41) Comparison of Branched DNA (B-DNA) and Polymerase Chain Reaction (RT-qPCR) Method Validation for the Quantification of mRNA Therapeutics in Plasma

(W1030-06-36) Novel Technical Breakthrough: qPCR with Reported LLOQ of 8 Copies / mg DNA in a 20 µL Reaction

(T1030-06-36) Sanger Sequencing of Oligonucleotide Pharmaceuticals

(M1030-06-36) Stabilization of Human Cells for RNA Extraction Using Capillary-Mediated Vitrification Process

(M1030-06-37) Strategies and Case Studies to Develop Ultra-sensitive LC-MS/MS Assays for Quantification of Inhalation Drugs in Human Plasma

(T1030-06-37) Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System

(M1030-06-38) Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody

(T1030-06-38) Optimizing Flow Cytometric Immune Phenotyping and CAR Persistence Determination to Enable Immune Monitoring of Patients under CAR T Cell Therapy

(W1030-06-38) Use of Human Plasma as a Surrogate Matrix for Quantitation of Modified Protein Therapy across Multiple Tumor Tissues

(W1030-06-39) Comprehensive LC-MS/MS Analysis of VSV-GP Lipidome

(T1030-06-39) Optimal Mobile Phase and Antisense Oligonucleotide Modifications for the Internal Standard in Bioanalysis of Therapeutic Oligonucleotides by Ion-Pair LC-MS/MS

(M1030-06-39) Robust Quantification Method Development for Antisense Oligonucleotide by LC-MS/MS

(T1130-06-36) Method Development of BI-X ADC Gyrolab Assay for the Determination of Anti-BI-X Antibodies

(W1130-06-36) Understanding Synthetic High-Density Lipoprotein Remodeling Ex Vivo Using Human Serum

(W1130-06-37) Validation of an In Vitro Cell-Based Assay for the Detection of Neutralizing Antibodies against Adeno-Associated Virus 9 in Cynomolgus Monkey

(T1130-06-38) Development and Validation of a Novel ECL Method for the Quantitative Detection of Complement C3 in Human Serum

(M1130-06-38) Innate Immune Response Modulating Impurities Assay for Assessing Synthetic Semaglutide and Liraglutide

(W1130-06-39) Bioanalysis of Endonuclease Cas9 in Plasma Conducing to Clarify CRISPR-Cas9-Mediated Genome Engineering Using Immunocapture followed with LC-MS/MS Screener Application

(M1130-06-39) PABE: A Novel Enhanced Drug Tolerant Assay Format to Detect Anti-Drug Antibodies in the Presence of High Concentrations of rhAAT-Fc

(T1130-06-39) Targeted Profiling of Lipid Mediators as Serum Biomarkers of Inflammation in a Case Study

(M1130-06-40) Development and Validation of a Sensitive Hybridization-Electrochemiluminescence (H-ECL) Method for Quantitation of STK-002, an Antisense Oligonucleotide, in Human Serum

(W1130-06-40) Validating Digital Droplet PCR (ddPCR) Assay with Zero-Inflated Poisson Model

(T1230-06-36) Development and Validation of an LC-MS/MS Method for the Quantification of Hydrogen Sulfide in Isolated Tissues from Porcine Eyes

(W1230-06-36) LC-MS/MS Method Development and Validation for Quantitative Analysis of CART Peptides in Cell Culture Supernatant and Human Plasma

(M1230-06-36) Method Development and Validation of a Sensitive and Robust Human Serum PK Immunoassay for a Novel Bispecific Antibody by an Automated Microfluidic System

(M1230-06-37) Development of a Sensitive and Specific Phospho-Tau 217 [Tau (pT217)] Biomarker Assay for Alzheimer’s Disease in Plasma and Serum

(T1230-06-37) Expansion of the Human Immuno-Oncology Assay Portfolio on a Multiplexed Electrochemiluminescence Platform

(W1230-06-37) PD-L1 Gene Expression Quantification in Single Cell on Tissue for Accurately Predicting Response to ICIs

(M1230-06-38) Evaluation of Free vs Total Measurement of Monoclonal Antibody-Based Therapeutics with Low Binding Affinity to Soluble Target

(W1230-06-38) Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies

(T1230-06-38) Performance of a Digoxigenin Antibody-Based Electrochemiluminescent Hybridization Assay: A HELISA Alternative for Low Femtomolar Detection of an Antisense Oligonucleotide

(T1230-06-39) Prediction of Hematocrit through Potassium Measurement in Whole Blood Using Volumetric Absorptive Microsampling

(M1330-06-36) Determination of Microdystrophin (h-µD5) via Signature Peptide Analysis in Muscle Tissue by LC-MS/MS

(T1330-06-36) Duplicate-Well vs Single-Well Analysis in Ligand Binding Assays (LBAs): A Retrospective Comparison of Method Validations and Nonclinical Toxicokinetic (TK) Sample Analyses Data

(M1330-06-38) Comparison of Manual and Automated Nucleic Acid Extraction Methods

(T1330-06-38) Rapid Quantitation of Docosahexaenoic Acid and Its Hydroxy Metabolites in Liver Cells Using Differential Mobility Separation (SelexION) Coupled with Liquid Chromatography Tandem Mass Spectrometry

(M1330-06-39) Regulatory Perspective of Considerations in Endogenous Therapeutic Analyte Bioanalysis

(M1330-06-40) A Comprehensive Bioanalytical Strategy of In Vivo Studies for RNAi Therapeutics in Early Discovery

(T1430-06-36) Immunogenicity Assessment: A Comparative Study between a Chemically Labeled and an Enzymatically Biotinylated rAAV9 Vector

(M1430-06-36) Qualification of a Neurology 2-Plex B (Nf-L, GFAP) Quanterix Simoa® Assay Using a Novel Approach

(T1430-06-37) Quantum Electrochemical Spectroscopy (QES): A Novel AI-Driven Spectroscopic Approach to Simplify Bioanalytical Development in the Pharmaceutical and Biotech Industries

(M1430-06-37) Toward Development of a New QCM-D Based Method for Rapid Detection of a Novel Biomarker of Morbidity and Mortality Risk in Sepsis Patients

(T1430-06-38) Content Uniformity, Drug Quantification and Cross-Reactivity Analysis of Protein Loaded PGSU Implants Using Raman Spectroscopy and Reverse-Phase High Performance Liquid Chromatography (RP-HPLC)

(M1430-06-39) A Comprehensive Array of Bioanalytical Assays to Assess the Pharmacokinetic Properties of Antibody-Drug Conjugates In Vivo and In Vitro

(T1430-06-39) A Process of Method Development for Tissue Homogenization and Analysis to Eliminate Binding and Matrix Effects Using Surrogate Matrices

(M1430-06-40) Development of an Ultrasensitive qPCR Method to Identify and Quantify Point Mutation in Circulating Tumor DNA

(T1430-06-40) Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Pharmacokinetics of PTH-IA in Mice

(T1530-06-36) An End-to-End One-Pot Immunoaffinity-LC-MS/MS Assay for Simultaneous Quantitation of Total and Conjugated Antibody Levels of Antibody-Drug Conjugates with Protease-Cleavable Linkers

(T1530-06-38) Out of Endotoxin Box: Rethinking Pyrogens

(T1530-06-39) A Two-Part Method for the Separation and Quantification of Free and Encapsulated ASOs by Hybridization ELISA

(T1530-06-40) Analyzing Insulin Glargine Biosimilars: Stability, Degradation, and Structural Characterization

(M0930-06-38) Quantitation of Bemnifosbuvir and Metabolites in Human Bronchoalveolar Lavage (BAL) by LC-MS/MS

(M0930-06-40) Increased Throughput for Regulated Bioanalysis with Catch-and-Hold Mode of HPLC Separation with High Sensitivity Mass Spectrometers

(T0930-06-40) Optimizing Discovery Bioanalytical Strategy for Macrocyclic Peptides and Degraders with Orbitrap High Resolution Mass Spectrometry

(T1030-06-40) Detection and Quantification of Gentamicin in the Inner Ear Using Different Liquid Chromatography Methods

(W1030-06-40) Gastrointestinal Digestion and Fermentation of Astragalus membranaceus Polysaccharides

(M1030-06-40) Optimizing Detector Settings for Method Scaling-Meeting System Suitability Criteria

(M1130-06-36) Characterization of Blueberry-Derived Exosomes: New Insights into a Potential Nanomedicine

(M1130-06-37) Bioanalytical Assessments of a Novel Approach to Overcome Microsampling Challenges in Rodent Studies

(T1130-06-37) Establishment of an LC-MS/MS Method for Quantification of Lifitegrast in Rabbit Ocular Tissues and Its Application to Pharmacokinetic Study

(W1130-06-38) Utilizing Organic Solvents for Residual Solvent and Volatile Impurity Analysis of Water-Insoluble Articles Using SIFT-MS

(W1230-06-39) Simultaneous LC-MS/MS Method for the Quantitation of Azithromycin, Hydroxychloroquine and its Metabolites In SARS-CoV-2(-/+) Populations Using Dried Blood Spots

(M1230-06-40) Cetuximab-Based Proteolysis Targeting Chimera for Effectual Downregulation of NSCLC with Varied EGFR Mutations

(T1330-06-39) Pharmacokinetic and Pharmacodynamic Correlations of Riluzole and Etoricoxib in a Long-Evan Rat Model with Traumatic Brain Injury

(M1430-06-38) Smart Compound Library Based on Machine Learning, Sensing Technology, and Programmable Logic Control

(T1430-06-41) Research Strategy of Chiral PROTACs in Discovery Stage Based on Analysis Platforms of UPCC-MS/MS and UPLC-MS/MS

(T1530-06-37) A Study of the Effects of Water and other Modifier Additives on the SFC Separation of Ritonavir

(T0930-04-22) A Complete Automation Solution Using an Acoustic Ejection Mass Spectrometry System for Rapid Sample Analysis

(M0930-04-23) Beneficial Effects of Trehalose on Mesenchymal Stem Cell-Derived Exosomes

(T0930-04-23) Impact of a Novel Thin Film Platform on the Uptake and Permeability of Virus-Based Vaccines in an In Vitro Model of the Human Oral Mucosa

(W0930-04-23) In Vitro Synergism of Depolymerase-Antibiotic Combination against Multidrug-Resistant Acinetobacter baumannii

(M0930-04-24) Design and Synthesis of Conformationally Modulated Rutinose Saccharides and Their Conformational Analysis by NMR

(T0930-04-24) Urea-Based Compound UR-1-1-13 Affects the Mitochondrial Health of Triple-Negative Breast Cancer Cells

(M0930-04-25) A Compatibility Test of Two-Piece Hard Capsules and Liquid/Semi-solid Excipients - Part 2

(T0930-04-25) ISMICAP: A Model for Delving into Blood-Brain Barrier Mysteries

(W0930-04-25) Physiologically Based Pharmacokinetic (PBPK) Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products

(T0930-04-26) A New Class of Lipids Conjugated to Poly(ethylene glycol) Structural Isomers: An Efficient Approach to Evade Immune Recognition of Lipid Nanoparticles

(W0930-04-26) A Novel Poly(N-isopropylacrylamide)-based Thermoresponsive Bioink for DLP Bioprinting

(M0930-04-26) Sodium Butyrate Decreases VCAM-1 Expression by Inhibiting Stat3/GATA6 Signaling Pathway in Alzheimer’s disease

(T0930-04-27) DNA Hydroxymethylation and TET Enzymes Changes Induced by the Curcumin Analog Dimethoxycurcumin

(M0930-04-27) High-Resolution Sequencing Comparison of the DNA Methylome and Hydroxymethylome in Leukemia and Normal Blood Cells

(W0930-04-27) Novel Blood Pressure Lowering Effects of Statins

(T0930-04-28) ABCB1 and HMGB1 Gene Polymorphism and Adverse Reactions to Carboplatin and Paclitaxel Treatment in Patients with Non-small Cell Lung Cancer

(M0930-04-28) Associations of Polymorphisms of the ABCB1 and ABCC2 Genes with Cisplatin-Induced Nephrotoxicity and Myelosuppression in Patients with Head and Neck Cancer

(W0930-04-28) Enhanced Cytotoxic Effect of Paclitaxel in Combination with Calcipotriol on Human Pancreatic Cancer Cells

(W0930-05-29) Contribution of High-Speed In-Line Inspection to Automated and DoE-Based Development of Tablets

(W0930-05-30) Comparison of Paclitaxel Distribution across CNS and PNS Barriers after Administration of Cremophor EL/Ethanol Solubilized, Albumin-Bound and Micellar Paclitaxel

(M0930-05-30) Dynamic In Vitro Cell Culture Model to Study Pathogenic Interactions in Periodontitis In Flow Using a Lab-on-a-Disc Platform

(M0930-05-31) Assessment of Stability and Erosion Behavior of ASDs by Using VCM Technique

(W0930-05-31) Repurposing Amodiaquine as a Dry Powder Inhaled Formulation for Respiratory Disorders

(W0930-05-32) Repurposing an Antiviral Peptide to Inhibit Tumor-Derived Exosomes for Synergistic Cancer Immunotherapy

(M0930-05-32) Theoretical and Experimental Polymer-Polymer Miscibility Prediction: An Insight to In Vivo Compatibility

(M0930-05-33) Development of a Water-Soluble Mini-Tablet Formulation for Flow Cytometry Applications

(W0930-05-33) Regulation of Rat Hepatic Monocarboxylate Transporter Expression by Sex and Cross-Sex Hormone Treatment

(W1030-04-22) Combination Therapy of Geranylgeranyl Diphosphate Synthase Inhibitor and Fatty Acid Synthase Inhibitor in Multiple Myeloma

(T1030-04-22) Impact of Solvent Choice in the Spray-Freeze-Drying of Insoluble Excipients

(W1030-04-23) Promising Mouse Models for Premetastatic Niche

(M1030-04-23) Using Molecular Probes to Dissect and Control the Energetics of Liquid-Liquid Phase Separation in a Model Intrinsically Disordered Protein System

(T1030-04-24) A Simple and Facile Platform for Semi-Solid Extrusion of Different Formulations Containing a Drug-Loaded Mesoporous Material

(W1030-04-24) Diethyldithiocarbamate Copper Nanoparticle Overcomes Resistance in Cancer Therapy without Inhibiting P-glycoprotein

(M1030-04-24) Synthesis of Rhenium Tricarbonyl Phenformin Complex as an Anticancer Theragnostic Agent and Development of LC-MS/MS Assay for Pharmacokinetic Study

(M1030-04-25) Predictive Model to Determine the Aqueous Solubility of BCS Class IV Drugs in Amorphous Solid Dispersions

(W1030-04-25) The Estimates for the Absorption Rate Constant in Pharmacokinetics and Pharmacometrics Are Wrong: A New Era Based on the Finite Absorption Time Concept Rises

(M1030-04-26) Impact of Host Physiological and Pathological Conditions on the Activity of Gut Microbial Beta-Glucuronidases (GUS) toward Hydrolysis of Flavonoids-Glucoronides

(T1030-04-26) Oral Cavity Permeability Assessment Using Sublingual and Buccal In Vitro Tissue Models

(W1030-04-26) Tigecycline Pharmacokinetics after Intrapulmonary Administration in Mice

(T1030-04-27) Identification of FDA-Approved Drugs Targeting Malonyl Co-A Decarboxylase for the Treatment of Obesity

(M1030-04-27) Neflamapimod Inhibits Endothelial Cell Activation and Leukocyte Adhesion by Inhibiting p38 MAPKα and NF-κB Signaling

(T1030-04-28) Co-administration of Irinotecan with Naturally Occurring Flavonoids Exhibits Synergistic Antitumor Effects on Colon Xenograft Tumors

(M1030-04-28) Comparative Cell Viability Study for Paclitaxel Loaded PLGA-PEG Nanoparticles in Established U-87 and Patient Derived Primary GBM10, GBM39, GBM43 and GBM75 Glioblastoma Cells

(W1030-04-28) Differential Modulation of Endoplasmic Reticulum Calcium Pumps SERCA2 and SERCA3 in T Lymphocytes by Small Molecule Allosteric SERCA Activator CDN1163

(W1030-05-29) Pharmacokinetics of the Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Semaglutide in Rats

(W1030-05-30) Drug Delivery Optimization and Nutraceutical as Adjuvant with Antiretroviral Therapy to Suppress HIV-1 in CNS Reservoirs

(W1030-05-31) Pericyte Control of Gene Expression in the Brain Endothelium: Implications for Alzheimer’s disease

(W1030-05-32) Use of DEM to Troubleshoot Aesthetic Defects in Pharmaceutical Tablets

(W1030-05-33) Study on the Permeability of Ophthalmic Tissues In Vitro

(M1130-04-22) Mitochondrial Activity and Function are Modulated by KLF2 in Rheumatoid Arthritis

(T1130-04-22) The Effect and Distribution of Amorphous Nanosilica Particle in the Brain and Microglial Cells

(W1130-04-22) Valproic Acid Elevates HIF-1α-mediated CGB Expression and Suppresses Glucose Uptake in BeWo Cells

(M1130-04-23) Gut Microbial Metabolites Effect Intracellular Accumulation of Alzheimer’s disease Amyloid Beta Peptides at the Blood-Brain Barrier Endothelium

(W1130-04-23) Synthesis, Conformational Analysis, and Binding Studies of 6α-mannobiose Glycosides

(T1130-04-23) The Response of an Orthotopic Lung Cancer Xenograft Model to Cisplatin

(M1130-04-24) Collagen Droplet-Based Micro-Bioreactors for High-Throughput Drug Screening

(T1130-04-24) Downregulated Expression Levels of miR-451a and miR-185-5p as Potential Biomarkers for Coronavirus Disease 2019 (COVID-19) Severity

(W1130-04-24) Mebendazole Nanosuspension for the Treatment of Glioblastoma

(T1130-04-25) Extended In Vitro-In Vivo Correlation (IVIVC) Model to Predict the Pharmacokinetics of Ticagrelor Sustained-Release Formulations

(W1130-04-25) Software-Optimized Oligonucleotide Purification with Preparative HPLC/MS

(T1130-04-26) Investigation of a Novel Iron Chelator: A Pharmacokinetic and Pharmacodynamic Study

(W1130-04-26) Peonidin-3-O-Glucoside and Resveratrol Reduce Human hFOB Osteoblast Apoptosis and Alter the Expression of Genes Associated with Apoptosis, Differentiation and Osteoclastogenesis

(T1130-04-27) Anticancer Effects of Proteins and miRNAs Picked out by Proteomic Analysis of NK Cell-Derived EVs in Combination with Carboplatin in Resistant Lung Cancer: Role of PDL1/PD-1, SOD2, PARP, NF-kB and SET

(W1130-04-27) The Effect of MO-OH-Nap Tropolone on Osteosarcoma Cellular Metabolism

(M1130-04-28) Could the Plasmatic miRNAs hsa-miR-4433b-5p, hsa-miR-320b and hsa-miR-16-2-2p Be Biomarkers of Covid-19?

(T1130-04-28) Periplasmic Target Site Penetration Rates of Four β-Lactamase Inhibitors in Klebsiella Pneumoniae Carbapenemase-2 (KPC-2) Producing Klebsiella pneumoniae

(M1130-05-29) Synergistic Anticancer Activity of Cannabinoids and Terpenes in Xenograft Mouse Model of Triple Negative Breast Cancer

(M1130-05-30) A Robust, Viable, and Resource Sparing HPLC-Based logP Method Applied to Common Drugs

(T1130-05-30) Development of a Targeted Peptide-Drug Conjugate for the Treatment of Glioblastoma

(M1130-05-31) Antigen-Specific Tolerogenic Nanodiscs for the Treatment of Experimental Autoimmune Encephalomyelitis

(T1130-05-31) Development and Validation of Quantitative Analysis Method for Testosterone Derivatives in Natural musk(Moschus) Using GC-MS

(T1130-05-32) Global Identification of OATP1B1-Associated Proteins and Implications of Calcineurin Inhibition in Time-Dependent OATP1B1 Inhibition

(M1130-05-32) Targeted Transport of Active Pharmaceutical Ingredients into Adipose Tissue and Liver

(T1130-05-33) High-Density Lipoprotein Mimetic Peptide 4F Reduces Amyloid Beta Peptide Accumulation in the Blood-Brain Barrier Endothelium of Alzheimer’s disease brain

(M1130-05-33) Novel Caffeic Acid Phenethyl Ester (CAPE) Derivatives Inhibit Human Multiple Myeloma Cell Growth

(M1230-04-22) Effect of Lung Cancer Exosomal Galectin-3 Binding Protein on Bone Metastasis

(T1230-04-22) The Paracrine Action of Mutant p53 in Breast Cancer

(M1230-04-23) Molecular Mechanisms Driving Sex-Dependent Cerebrovascular Inflammation in Alzheimer's disease

(M1230-04-24) A Novel Electrospinning System to Fabricate Bi-axial Nanofibers for Developing a Floating Pharmaceutical Dosage Form

(T1230-04-24) Hyaluronic Acid Nanogel Cancer Vaccine: Powerful and Versatile Priming Tool for Combinational T Cell Therapy

(M1230-04-25) Biopharmaceutical Analysis of Synthesized Antibiotic Ester Prodrugs; Ciprofloxacin Isopentanoate, Ciprofloxacin N-Butanoate and Ciprofloxacin Isobutanoate

(M1230-04-26) Flow Cytometry and Confocal Microscopy to Quantify β-lactam Penetration in a Double β-lactamase and Double Efflux Pump Knockout Strain of Acinetobacter baumannii (AB)

(T1230-04-26) Mice Deficient in Interleukin 6 (IL-6) Show Improved Short-Term versus Long Term Memory following Methamphetamine Treatment

(M1230-04-27) Tangerine-Peel-Derived Nanovesicles Alleviate Hepatic Steatosis in Type 2 Diabetic Mice via Regulating Lipid Metabolism and Intestinal Flora Disorder

(M1230-04-28) Impact of In-utero Electronic Cigarette Exposure on Neonatal Neuroimmune and Mitochondrial Function

(M1230-05-29) AI and Experimental-Based Discovery and Preclinical IND-Enabling Studies of Selective BMX Inhibitors for Development of Cancer Therapeutics

(T1230-05-29) Finding the Alternative Path: Formulation Strategies for Sustained Release of Challenging Small Molecule Compounds

(M1230-05-30) Application of Quantitative Models to Systematically Evaluate Factors Impacting Swallowability of Tablets

(T1230-05-30) Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles

(M1230-05-31) Impact of Pre-incubation on BCRP and P-gp Transporter Inhibition in the Membrane Vesicle Assay

(T1230-05-31) Pharmacokinetics and Interspecies Scaling of Semaglutide, a GLP-1 Receptor Agonist

(T1230-05-32) Regulation of OATP1B3 Transport Function via Protein Acetylation

(M1230-05-32) Using a Semi-Mechanistic Model to Predict Efficacious Dosing Regimens and Optimal Drug Design Properties for a LNP-Delivered mRNA UGT1A1 Replacement Therapy in Crigler-Najjar Syndrome Type 1 Patients

(M1230-05-33) Concurrent Regulation of OATP1B1 Transport Function by Protein Phosphorylation and Acetylation: Novel Mechanism Underlying Reduced Function of OATP1B1 c.521T >C Single Nucleotide Polymorphism

(T1230-05-33) Renal Monocarboxylate Transporter Expression in Response to Female Sex and Cross-Sex Hormone Treatment

(T1330-04-22) Cell Culture Media Monitoring in Cell and Gene Therapy Supporting Upstream Bioprocessing

(M1330-04-22) Investigation of Molecular Interactions between Active Pharmaceutical Substances and Polymer Excipients Using 1H-NMR

(T1330-04-23) Discovery of Anti-Transforming Growth Factor β Receptor II (TGFβRII) Cyclic Peptides

(M1330-04-23) The Search for HIV Latency Reversing Selective HDAC3 Inhibitors Through Virtual Screening

(T1330-04-24) Characterization of Particle Disposition following Intranasal Inoculation with a 3D Printed Device

(M1330-04-24) Understanding Mechanisms behind Low Conjugation Efficiencies of Thiol-Maleimide Reactions to Synthesize Antibody-Drug Conjugates

(M1330-04-25) Endothelial Cell-Pericyte Interactions Regulate Brain Glucose Transport

(T1330-04-25) The Impact of Surface Area per Volume Ratio on Drug Transport from Supersaturated Solutions of Ketoconazole

(T1330-04-26) Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-Release Nifedipine: Physiologically Based Pharmacokinetic Modeling

(M1330-04-26) Urinary MicroRNAs as Possible Biomarkers of Cisplatin-Induced Nephrotoxicity in Patients with Head and Neck Cancer

(M1330-04-27) Activating 5-HT 1A Receptors as a Treatment for Fragile X Syndrome: A Preclinical Study in Fmr1 Knockout Mice

(T1330-04-27) Effect of Propofol on Lipid Membrane Fluidity and Blood-Brain Barrier Permeability

(T1430-05-29) Chiral Separation of Triacyclglycerols Isomers by Supercritical Fluid Chromatography

(T1430-05-30) The Use of Short 10 mm Columns for Ultra-fast LC-MS Analyses

(T1430-05-31) Analysis of Pharmacogenetic Polymorphism Effect of ABCB1 2677G >T/A Through Molecular Modeling Approach

(M1430-05-31) Effects of Testosterone on Kidney Monocarboxylate Transporter Expression

(M1430-05-32) Tetrahydrocurcumin, a Metabolic By-Product of Curcumin, Shows Neuroprotection: A Potential Therapeutic Metabolite for Neurodegenerative Pathologies

(T1430-05-32) The Printability of an Alginate-Based Hydrogel and Its Compatibility with NIH-3T3 Cells

(M1430-05-33) Barrier Properties of Pharmaceutical Polymers – Novel Applications for Protecting Respiratory Membranes from Pathogens

(T1430-05-33) Engineering Human Liver Spheroids with Biomimetic Nanoscaffolds for Preclinical Test of Drug-Induced Liver Injuries

(T1530-05-29) Discovery of a Deazaflavin Analog as Potent and Selective Inhibitor of Multidrug Resistance-Associated Protein 1 (MRP1)

(M1530-05-29) The Effect of Cancer-Associated Cachexia on the Pharmacokinetics of Extra-vascularly Administered Monoclonal Antibodies

(T1530-05-30) Discovery of Oral Vaccine Adjuvant via Bioanalytical HTS Assays

(M1530-05-30) Metformin Induced-Oxidative Stress Modulates LNCaP Cellular Redox Status and Suppressed Cell Growth

(T1530-05-31) A Novel Dissolution Model to Study the Release and Uptake of Oral Lymphotropic Drug Products

(M1530-05-31) Anti-cancer Sonosensitive DOX-Loaded Liposomes to Avoid Systemic Immunosuppression

(T1530-05-32) Topical Dexpanthenol Modulates Microbially Induced Inflammation in a 3D Corneal Model: A Proteomic Analysis

(M1530-05-33) Advancing Lung Cancer Therapy: Development and Optimization of Lorlatinib Loaded Inhaled Nanostructure Lipid Carriers (NLC) Using Design of Experiment Approach

(T1530-05-33) Characterizing the Pharmacological Mechanism of Agmatine in the Spinal Cord Using Calcium Imaging and NMDA-induced Behavioral Assays

(M0930-05-29) Benchmarking Large Multi-task Machine Learning Models for ADME, Toxicology and Drug Discovery Endpoints

(T1130-05-34) Digestion Is an Important Element for Absorption of Cinnarizine from Supersaturated Lipid-Based Type II Formulations

(M1330-04-28) Permeability of Metformin across the Blood-Brain Barrier: Repurposing a Potential Neurotherapeutic for Ischemic Stroke

(M1430-05-30) High-Throughput 3D Bioprinting of Corneal Stromal Equivalents

(M0930-01-01) Brain-Targeted Oxytocin Nanoparticles Formulated via Microfluidics for Epilepsy

(W0930-01-01) Targeting TNBC Tumor Using Hypoxia-Responsive Nanoparticles containing Synergistic Drug Combinations

(W0930-01-03) Developing a Platform for Formulation Screening of High Concentration Monoclonal Antibodies (mAbs)

(W0930-01-05) Assessment of Phenol and Benzyl Alcohol for Use as Preservatives in mAb Drug Therapies

(W0930-01-06) Intranasal Delivery of pApoE to the Brain for Developing Effective Therapeutics for Alzheimer’s disease

(M0930-02-08) A Novel Immunization Strategy against Malaria Using Microneedles and Virus-Like Particles Vaccine

(M0930-02-09) Combating SARS-CoV-2 Variants: Pain-Free Bivalent Intranasal Vaccination Delivery

(T0930-02-10) Engineered Anti-CD40 Agonist Antibody as a Novel Cancer Neoantigen Vaccines

(W0930-02-10) Evaluation of the Effect of the Backing Layer Formulation on Dissolvable Microneedle Properties

(M0930-02-14) T Lymphocyte Proliferation in Response to Microparticulate Vaccine Candidates against H1N1 Flu and Neisseria gonorrhea Pathogens

(T0930-03-15) In Vivo Confirmation of the Permeation Enhancement Capacity of Labrafac™ MC60

(W0930-03-15) Oral Delivery of Probiotics Using Delayed-Release Capsules: Formulation and Dosage Form Considerations

(M0930-03-16) New Insight into the Oral Delivery Mechanism of Semaglutide Based on All-atom Molecular Dynamics Simulations

(T0930-03-16) Remote Loading of Setmelanotide in Poly(lactic-co-glycolic acid) Microspheres for Long-Term Obesity Control

(M0930-03-51) Boosting Antitumor Immune Response against Breast Cancer Cells Using Doxorubicin and Zinc Oxide Nanoparticles Co-loaded Lipid Nanocarrier

(T0930-11-71) Development of a Novel Tacrolimus Loaded Thermoresponsive Nanoemulgel for Local Immunomodulation in Organ Rejection

(M0930-11-72) Drug-Free Bioresponsive Hydrogel for On-Demand Contraception

(W0930-11-73) Oral Tablets Containing a Model Protein API – Impacts of Excipient Selection, API Loading, Unit Operation, and Manufacturing Process Parameters on Tablet Properties, Performance, and Stability

(T0930-11-74) Microbicide-Containing SMART Gel for Female-Controlled Multipurpose Prevention

(W0930-12-77) An Insight into the Interrelationship between Colloidal Stability of Protein Therapeutics in Formulation and Their Adsorption to a Solid Surface

(T0930-12-77) Bioinspired Nanoerythrocytes for Metabolic Microenvironment Remodeling and Long-Term Prognosis Promoting of Acute Ischemic Stroke

(M0930-12-77) Low Dose Compatibility Testing With and Without Surfactant in Polyethylene Terephthalate (PETG), Glass, and Polypropylene Container Types for Large Molecule Analysis

(M1030-01-01) Breaking the Pain Barrier: Innovative Strategies for Administering a Whole Cell Inactivated Microparticulate Gonorrhea Vaccine

(M1030-01-05) Thrombocytopenia Protective Quetiapine Hemifumarate-Loaded Nasal Nanoemulgels for Schizophrenia

(T1030-02-08) Adjuvanted Ionizable Lipid Nanoparticles for mRNA Delivery

(W1030-02-08) Characterization of In Situ Forming Implants Using CT Imaging

(M1030-02-10) Dual Functionalized Liposomal Nanoparticles Can Deliver Plasmid Encoding for Angiotensin II Receptor shRNA to the Brain of Spontaneously Hypertensive Rats to Reduce Blood Pressure

(W1030-02-10) Evolving Component Technologies to Meet the Needs of Large Volume Injections

(W1030-02-12) Pain-Free Alternatives for Vaccinating against the Zika Virus Using 3D Printed Orally Dissolving Films (ODF) and Intranasal Drops

(W1030-03-15) Controlled Release of TLR7/8 Agonist-Manganese from PLGA Microparticles for Enhanced Cancer Immunotherapy

(T1030-03-15) Expanding the Space of Hydroxyl-Rich Lyoprotectants through High-Throughput Screening to Support the Lyophilization of Yeast-Based Therapeutics

(M1030-11-70) Controlled Release Edaravone Nanosuspension: A Translational Therapeutic Approach for the Prevention of Preterm Birth

(W1030-11-71) Development of Tablets with Biologics: Effect of Freeze-Dried and Spray-Dried Powders on the Compaction Behavior

(M1030-11-72) Guided Assembly of Lymph Node Stromal Cells Using a Biomaterial Formulation

(W1030-11-75) Systemic Coadministration of Selective PDE4B Inhibitor A-33 and the Pan-PPAR Agonist Lanifibranor Ameliorates Chronic Liver Disease

(M1030-12-77) A Study on the Visible Aggregation of a Peptide Formulation Under Stress Conditions at Manufacturing Fill and Finish Process

(W1030-12-77) Application of Machine Learning to the Development of Lipid Nanoparticle

(T1030-12-77) Developing an In Situ Hyaluronic Acid-Tyramine Hydrogel Platform to Deliver Extracellular Vesicles

(T1130-01-01) Acoustic Levitation: A Novel Experimental Tool to Study Drying Kinetics and Particle Formation of Pharmaceutical Excipients

(M1130-01-03) A Clinical Study to Assess the Bioequivalence of Topical Diclofenac Products Using Dermal Open Flow Microperfusion

(W1130-01-04) Biodegradable Nanogels for Controlled Release of Artemisinin-Derived Drug to Treat Leukemia

(W1130-01-05) Fibronectin (FN) Binding Efficacy of PEGylated FUD (PEG-FUD) Peptide in Bleomycin Treated Animal Model for the Treatment of Pulmonary Fibrosis

(M1130-01-05) Toward Enhanced Stability of mRNA Lipid Nanoparticles

(T1130-01-06) Cyclodextrin Modulation of Lanreotide Gel Formation and Diffusional Release from an Emulated Subcutaneous Delivery Device

(M1130-01-07) Map the Formulation Space of Lipid Nanoparticles (LNPs) Using Microfluidic Assembly in the Intraperitoneal (IP) Administration of RNA Therapeutics

(T1130-02-08) An Oleic Acid-Conjugated Vaccine Antigen for Enhanced Physicochemical Properties and Thermal Stability via Self-Assembled Nanonization

(W1130-02-11) Interaction between Different Types of Excipients and Protein

(W1130-02-12) Polydopamine-Coated Nanoparticles as a Targeted Drug Delivery System for the Treatment of Helicobacter pylori-Infected Gastric Ulcer

(T1130-03-15) Albumin corona Improves Colloidal Stability of Nanosac, the Non-cationic Polyphenol Gene Carrier

(W1130-03-15) On-Demand Multi-Indication Fast-Dissolving Inserts (FDIs) for Birth Control and HIV Prevention

(M1130-03-15) Synergistic Chemotherapy for Prostate Cancer Mediated by Brusatol and Docetaxel-Loaded Nanoparticles: Cell Cycle Arrest and Apoptosis Mechanisms

(T1130-03-16) Deaeration Enhances the Cryoprotective Effect of Tween 80 on Denaturation of Bovine IgG during Thin-Film Freezing

(M1130-03-16) Enteric Functional Ready-to-Fill Capsule Solution from Pre-Clinic to Commercial

(T1130-11-71) Predicting the Stability of Lyophilised Protein Mixtures with Terahertz Spectroscopy

(M1130-11-72) Effect of Tetanus Toxoid Fragment C (TT_c) and Transferrin (T_f) Functionalized Liposomal Nanoparticle Encapsulating Plasmid APOE2 for the Treatment of Alzheimer’s Disease

(W1130-11-73) IR-820 Dye-Based Layer-by-Layer Inhalation System as a Theranostic Agent for Non-invasive NIRF Imaging of Tumor Margins in Lung Cancers

(W1130-11-75) Tailoring Ligand-Altered Nanostructured Lipid Carrier for the Brain Delivery of Anti-cancer Drug cum herbal Compound for the Treatment of Glioblastoma Multiforme

(M1130-12-77) Stabilization and Formulation Development of Lipid Nanoparticles (LNPs) for Nucleic Acid-Based Therapeutics

(T1130-12-77) Vitamin D and Insulin Microparticle Incorporation into 3D-Printed Gene-Activated Calcium Phosphate Cement Scaffolds for Bone Regeneration Applications

(T1230-01-02) Immunity for the Long Haul: Exploring Cross-Protectivity against Emerging Strains upon Vaccination with Gonococcal Vaccine Microparticles in Mice

(T1230-02-09) Development and In Vitro Evaluation of Donepezil, Memantine and siRNA Encapsulated Liposomes

(M1230-02-10) Effect of Homotypic vs Heterotypic Interactions on the Cellular Uptake of Extracellular Vesicles

(M1230-02-11) Formulation and Biological Evaluation of Spray Dried Microparticles Loaded with LL37 Antimicrobial Peptide

(W1230-02-11) Intestinal Delivery of Live Biotherapeutic Products by pH-Sustaining Hydrogels and Their Therapeutic Efficacies on DSS-Induced Colitis

(T1230-02-13) Reduction of Blood Pressure in the Spontaneously Hypertensive Rats via the Nose-to-Brain Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA

(T1230-03-15) Controlled Release of Monoclonal Antibodies from Long-Acting PLGA-Coated Implants

(W1230-03-15) Development of Aerosolizable mRNA Incorporated Chitosan Nanoparticles for Efficient Lung Delivery

(M1230-03-15) Fabrication of Eco-Benign Isoniazid-Loaded-Silver Nanoparticles: A Novel Approach against Multidrug-Resistant Tuberculosis

(T1230-03-16) Conjugation Chemistry of Antibody-Liposome Conjugates Affects Performance via Complement Activation and Mechanisms Thereof

(M1230-03-16) Systemic Delivery of Paclitaxel by Find-Me Nanoparticles Activates Anti-tumor Immunity and Eliminates Tumors

(W1230-11-73) Lipid Nanoparticles versus Lipoplexes: Optimizing Complexing Head Group and Formulation Technology for Efficient Gene Delivery

(T1230-11-74) Novel Gene Therapy for Drug-Resistant Melanoma: Synergistic Combination of PTEN Plasmid and BRD4 PROTAC Loaded Lipid Nanocarriers

(W1230-11-74) Predicting Stability of Lyophilized mRNA/LNP Formulations Using Solid State NMR

(W1230-11-75) The Application of Machine Learning in Predicting Bioink Printability

(T1230-12-77) Analytical Characterization for Nucleic Acid Therapy: A Case Study

(M1230-12-77) Cellular Uptake and Real-Time ROS Sensing of Doxorubicin-Loaded Self-Assembled Albumin Nanoparticles Using Liver Bilayer Microfluidic Chip System

(T1330-02-12) Novel Bio-Active Peroxisomal Proliferator Activating Receptor Gamma (PPARγ) Hydrogel for Periodontitis Management

(M1330-03-15) Effect of Atomic Layer Coatings on the Stability of Solid Myoglobin Formulations

(T1330-03-15) Viable Eukaryotic Cell Dry Powders Prepared by Thin Film Freeze-Drying

(M1330-03-16) Mutant mRNA Encapsulated Aptamer Conjugated-Lipid Nanoparticles for Targeting Heart Cells

(T1330-03-16) pRNA Nanoparticles for Ocular Delivery: Pharmacokinetics and Pharmacodynamics After Subconjunctival Injection

(M1330-11-70) A Novel Approach to Formulation Screening of High Concentration Recombinant Human Heparan-N-Sulfatase (rhHNS) Using High-Throughput Devices

(M1330-11-75) Reversible, Covalent DNA Condensation Approach via Chemical Linkers for Enhanced Gene Delivery to Nucleus

(M1330-11-76) Triggering Mucosal Immunity: An Intranasal Combination Vaccine for COVID-19 and Influenza

(T1330-12-77) Delivery of Therapeutic Plant-Derived Exosomes to the Brain for the Treatment of Mental Health Disorders and CNS Injuries

(M1330-12-77) Dual Functionality of Poloxamer 188 in Freeze Dried Protein Formulations: A Stabilizer in Frozen Solution and a Bulking Agent

(M1430-01-01) Drug Loading Efficiency of a Topical Anorectal Wipes: A Wipe Impregnation Study

(T1430-01-01) Osimertinib Immunoliposomes as Inhaled Therapy for Non-small Cell Lung Cancer Treatment

(T1430-01-03) Exploring the Potential of Inhaled Nano Therapy for Malignant Pleural Mesothelioma

(T1430-01-04) Analysis and Simulation of In Vivo Nanoparticle Protein Carrier Pharmacokinetics

(M1430-01-06) Multi-functionalized Cationic Chitosan Polymeric Micelles for pVGF Delivery to the Brain through the Intranasal Route

(M1430-02-08) A Thermosensitive Hydrogel Formulation of Phage and Colistin Combination for Management of Multidrug-Resistant Acinetobacter baumannii Wound Infection

(M1430-02-10) Effects of Monomer on PLGA Based Long-Acting Injectables’ Release and Stability

(T1430-02-10) Evaluating Treatment Efficiency of RV and Kinase Inhibitor (KI) in Combination for Alzheimer’s disease: Cell Line Study

(M1430-03-15) Development of 3D Printable Inks for Protein Delivery

(M1430-03-16) Solubility Enhancement of Atorvastatin Calcium Trihydrate by Melt Extrusion

(T1430-03-16) Temperature Variations and Impurities Preclude a Reliable Measurement of the Diffusion Interaction Parameter for Monoclonal Antibodies

(M1430-11-71) Development and Characterization of RVG9R-Tansferrin Liposomal Nanoparticles Encapsulating Plasmid GFP for Targeted Delivery to the Brain

(M1430-11-73) Impact of Quantitative Differences in an Inactive Ingredient on the Performance of Topical Products Containing Lidocaine or Diclofenac Sodium

(T1430-11-73) Investigating Phase Separation of Trehalose during Lyophilization of Proteins Using Solid State NMR

(M1430-12-77) A Rational and Data-Driven Approach to Formulation of Therapeutic Peptides

(T1430-12-77) Development of a Dual-Drug Conjugate for Site-Specific Delivery to Prostate Cancer

(M1530-01-01) A Promising Peptide-Based Universal Vaccine against MERS-CoV and SARS-CoV2 Coronaviruses

(M1530-01-04) Heat Shock Protein-Loaded Mitochondria Containing Microvesicles Protect the Blood-Brain Barrier in Ischemic Stroke

(M1530-01-05) Nanosac: A Soft Nanocarrier for Systemic siRNA Delivery to Solid Tumors

(M1530-02-08) A Versatile Room Temperature Stable Lipid Nanoparticle COVID-19 Protein-Based Vaccine

(T1530-02-08) BIONDD^TM Oral Capsule Delivery of Liraglutide with Bioavailability Comparable to Subcutaneous Injection and Development of Efficient In Vivo Model in Dogs to Test Feasibility of Other Biologic Drugs

(M1530-02-14) β-catenin Inhibition Using XAV939 Nanoparticle Promotes Immunogenic Cell Death and Suppresses Tumor Progression

(M1530-03-15) Monitoring of Lidocaine Transport through Dermis and Subcutis into Muscle Tissue after Application via Topical Delivery Systems

(M1530-03-16) Robust Rugose Lipid Microparticles for Respiratory Delivery of Biologics

(M1530-11-74) Micellar Codelivery of DQ, a Disulfiram Based Prodrug with In Situ Copper Ions Chelation for Cancer Therapy

(M1530-12-78) Hot and Cold Formulation of Biologics for the Optimization of Drying Technologies

(T0930-01-01) Solid-State Properties and Phase Behaviors of Ephedrine Cyclamate

(W0930-01-02) Physical Stability of an Excipient System – How to Approach This Critical Performance Parameter?

(M0930-01-02) Predicting Compression Behaviors of Mixtures from Those of Individual Components

(M0930-01-03) A Bivariate Glass Transition Temperature/Molar Volume Empirical Model Predicts Mechanically-Induced Disordering with High Accuracy

(T0930-01-03) Nanostructured Lipid Carriers for Improved Ocular Bioavailability of Poorly Water-Soluble Drugs

(M0930-01-04) Development of a Sustained Release Softgel Dosage Form Based on Polyethylene Oxide Polymer

(W0930-01-04) Fabrication and Characterization of Amlodipine Besylate Based Sub-cutaneous Implants: Fabricated with the Help of Hot Melt Extrusion

(T0930-01-04) High Throughput Excipient Compatibility Screen Visualization and Analysis Using Spotfire

(T0930-01-05) Acceptable Solid Oral Dosage Forms for Older Adults as Prerequisite for Medication Adherence – The Current Situation

(M0930-01-05) Loratadine Nanosuspension-Loaded In Situ Gel: A Promising Thermo-Responsive Delivery System for the Treatment of Allergic Rhinitis

(T0930-01-06) Comparison of High Shear Granulation and Twin-Screw Granulation for Achieving High Drug Loading in Extrusion-Spheronization of a Highly Soluble API (Active Pharmaceutical Ingredient)

(M0930-01-06) Formulation and Characterization of Ionic Liquid-Containing (IL) Melatonin Orally Dissolving Films (ODFs) for Buccal Drug Delivery

(M0930-01-07) Three-Dimensional Extrusion Based Bioprinting of Metronidazole Immediate Release Tablets; Impact of Processing Parameters on In Vitro Evaluation

(T0930-02-08) Accelerating Development of FDM 3D Printed Medicines with Machine Learning

(W0930-02-08) Bupivacaine Hydrochloride Mucoadhesive In Situ Forming Gels for Oral Mucositis: Physiological Considerations

(T0930-02-09) Detailed In Vivo Evaluation of Novel Bioadhesive Microemulsion-Based Long-Acting Glaucoma Eye Drops

(W0930-02-09) Development of a Sustained Transdermal Delivery System of Amiloride for Management of Resistant Hypertension

(M0930-02-11) Exploring Phenylboronic Acid Conjugated pH-Sensitive Liposomes for Targeted Codelivery of Cisplatin-Chlorambucil Prodrug and Venetoclax for Triple-Negative Breast Cancer Management

(T0930-02-11) Formulation and Process Variables that Affect Tableting of Carbamazepine Dihydrate

(W0930-02-11) Influence of Coating Parameters on Uniformity and Yield of Immediate Release Coating Formulation of a Low Dose Drug (Linagliptin) onto Metformin HCl ER Tablets - Fixed Dose Combination

(M0930-02-12) Intradermal Injection of a Thermoresponsive Polymeric Dexamethasone Prodrug (ProGel-Dex) Ameliorate Dermatitis in an Imiquimod (IMQ)-Induced Psoriasis-Like Mouse Model

(T0930-02-12) Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease

(W0930-02-12) Orodispersible Minitablets with Taste-Masked Spray-Dried Dispersions: Tablet Compression and Electronic Tongue Assessment

(M0930-02-13) Predicting Food Effects of Commercial Products Using the Dynamic Gastric Model (DGM)

(W0930-02-13) Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery

(W0930-03-16) Development of Metformin HCL Sprinkles for Pediatric Oral Administration Using Hot-Melt Extrusion

(W0930-03-17) Development of Soluplus/TPGS Mixed Micelles Using Hot-Melt Extrusion for Hydrophobic Drug Delivery

(T0930-03-17) Fabrication of Caffeine Transdermal Film Using the Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing

(T0930-03-18) Development and Optimization of an In Vitro Release Assay for Evaluation of Liposomal Irinotecan Formulation

(M0930-03-18) Film-Coated Hard Capsules for Dry Powder Inhalers: Improving Inhalation Efficiency and In-Use Stability

(W0930-03-18) Impact of Formulation Composition, Lyophilization Processing Parameters and Freeze Dryer Configuration on Appearance of Lyophilized Finished Product

(W0930-03-19) Improved Distribution of Water Insoluble Components in Soluble Thin Film Formulations

(T0930-03-19) Temperature-Dependent Terahertz Time-Domain Spectroscopy as a Tool to Predict Crystallisation Tendencies of Amorphous Drugs

(M0930-03-19) The Effect of Controlled After-Melt Cooling Rate on Amorphization Degree of High-Drug Loaded Solid Dispersions of a Poor Glass-Forming Drug

(T0930-03-20) Impact of Tooling Size on the Heckel Profile and Derived Compressibility Parameters

(W0930-03-20) In Vitro Evaluation of Two Morphine Sulfate Extended-Release Products Sprinkled on Soft Foods

(M0930-03-20) Optimization of Roller Compaction Process Parameters for a Poorly Soluble Drug Using Quality by Design Tool

(M0930-03-21) Bioequivalence Prediction Based on In Vitro Flux Assay through the Example of Aripiprazole

(W0930-03-21) Dispersome^® a Viable Alternative toward Enhanced Drug Load and Bioavailability

(T0930-03-21) Improving the Solubility and Absorption of the Low-Solubility Compound Aripiprazole by Electrospinning Nanofiber Formulation

(M0930-11-70) A Comparative Study of In Vitro Itraconazole Drug Release from Amorphous Solid Dispersions (ASDs): Sempera® and Tolsura® under Fed State Conditions

(T0930-11-70) Amikacin Coated 3D-Printed Metal Devices for Prevention of Postsurgical Infections (PSIs)

(W0930-11-70) Assessment of Bio(in)Equivalence of Metronidazole Topical Formulations Using Stimulated Raman Scattering Microscopy

(M0930-11-71) Characterization of Compression Behavior of Co-processed Excipient for Production of Orally Dispersible Tablets and of Their Blends with Active Ingredient

(W0930-11-71) Development of Multiple Structured Pulsatile Release Tablets via Hot Melt Extrusion and Dual-Nozzle Fused Deposition Modeling 3D Printing

(T0930-11-72) Enhanced Transdermal Delivery of Lurasidone for Potential Treatment of Schizophrenia

(W0930-11-72) Investigating the Role of Critical Formulation and Process Variables Using Hybrid-Design Approach on the Redispersibility of Spray Dried Co-precipitated Nanoamorphous Micellar Dispersion

(M0930-11-73) Formulation Optimization of EVX-101, a Novel Gastro-Retentive Prolonged-Release 5-HTP/Low-Dose Carbidopa Tablet

(T0930-11-73) Implantable Albumin Gels for Biomimetic Delivery of Anticancer Drug for Breast Therapy

(M0930-11-74) Mannose Functionalized Chitosan Coated PLGA Nanoparticles for Cannabidiol Delivery to the Brain for the Treatment of Alzheimer’s disease

(W0930-11-74) Synergistic Effect of Bioenhancer for Increasing the Permeation of Lopinavir via Phospholipid Complexation

(W0930-11-75) Discovery and Development of Memantine Transdermal Patch

(M0930-11-75) Predicting the Stability of Amorphous Formulations Mixtures with Terahertz Spectroscopy

(T0930-11-75) Role of PLGA Variability in Controlled Drug Release from Dexamethasone Intravitreal Implants

(M0930-11-76) The Impact of Relative Humidity on In Vitro Permeation Test Method Performance Indicators, J_max, T_max and Amount Permeated for Molecule, TER-003

(T0930-12-78) Preparation and Evaluation of Dexamethasone Phosphate-Encapsulated Liposomal Gel Formulation for Intratympanic Delivery

(W0930-12-78) Process Induced Degradation of Carbamazepine during Hot Melt Extrusion

(W0930-12-79) Development of an Extended Release Nafamostat Formulation for Prescription Drug Overdose Protection

(M0930-12-79) Effect of Different Neutralizers and Their Concentration on Enteric Coating of Hypromellose Phthalate (HPMCP HP-50) and Drug Release in Various pH

(T0930-12-79) Transdermal Permeability Assay of LK 467, a Selective and Potent Agonist of the Melanocortin 1 Receptor, Demonstrating the Efficacy of Topical Application

(M0930-12-80) Development of Oral Bi-layer Tablet of Ruxolitinib

(T0930-12-80) Regulatory Challenges with Formulation Assessment of Parenteral Drug Products During ANDA Review: Case Studies and Considerations

(W0930-12-80) Stabilizing Amorphous Solid Dispersions: Polymer Blend Approach with PVP of Differing Molecular Weights

(W0930-12-81) Combination Therapy for the Reversal of Multi-drug Resistant Cancer

(T0930-12-81) Long-Acting Drug Delivery System for Subcutaneous, Intravitreal, and Intra-articular Administration using Hyaluronic Acid-Based In Situ Gelling Nanosuspension Formulation of Water-Insoluble Drugs

(T0930-12-82) Dexamethasone-Loaded Colon-Targeting UniORV^® with Improved Anti-inflammatory Effects and Reduced Risks of Systemic Side Effects

(W0930-12-82) Fabrication of Tip-Loaded Implantable PLGA Microneedles for Sustained Release of a Peptide- Carfilzomib

(M0930-12-82) Interaction of Thermal and Rheological Parameters Critical for the Processability of Polyvinyl Alcohol-Based Systems during Hot Melt Extrusion

(T0930-12-83) Co-micelle Technology by Hyaluronic Acid (HA) Nanogel (trade name Sonanos^TM) Solubilize as much of a Poorly Water-Soluble Drug as Possible with as Little as Possible

(W0930-12-83) Effect of Methylcellulose on Suspensions Based on Various Mixing Procedures and Temperature

(W1030-01-01) Investigating the Relationship between Material Attributes of API and the Extent of Powder Property Enhancement via Dry Particle Coating with Nano-Silica

(T1030-01-01) Nifuroxazide-Loaded Lipid Nanocarriers – An Effective Treatment against Lung Cancer

(T1030-01-02) Enhancement of Permeation of an Anti-Glaucoma Medication Brinzolamide via OcuSurf™ Lipid Nanoparticles

(M1030-01-03) A Case Study on the Applicability of the Refined Developability Classification System to Identify Compounds Suitable for Biowaivers: Voriconazole

(T1030-01-03) Critical Material Attributes (CMA) of Excipients in Topical Formulations: The Pitfalls of Switching between Compendial Raw Materials without a Full Analysis of all Critical Quality Attributes (CQA)

(W1030-01-03) The Design and Assessment of Sustained Release from PLGA/PEG Blend Nanoparticles for Intravenous Application

(M1030-01-04) Development of Customizable Swelling Vaginal Rings for Targeted Infection Treatment via 3D Printing

(W1030-01-05) Developing and Evaluating a Transdermal Patch of Lamotrigine for Potential Epilepsy Treatment

(T1030-01-05) Hydrophilic Polymers in Spray Dried Amorphous Dispersions - Exploring Polyvinyl Alcohol

(W1030-01-06) Felodipine Solubility Enhancement via Polymeric-Lipid Extrusion 3D Printing; Development and Stability

(M1030-01-06) Release Tunability of Exemestane from EVA Implants

(M1030-02-08) A Novel Liposomal Delivery for MicroRNA-497 and Venetoclax in Acute Myeloid Leukemia

(M1030-02-09) Combinational Approach Using AKT/ERK Dual Inhibitors for Pancreatic Cancer

(T1030-02-09) Development and Characterization of Highly Muco-penetrative PLGA Nanoparticles for theTreatment of Inflammation in Chronic Lung Disease

(W1030-02-09) Development of an Artificial Intelligence-Based PBPK Model for Nanoparticles in Tumor-Bearing Mice

(T1030-02-10) Enhancement of Optical Properties of Graphene Quantum Dots Using Nitrogen Doping: An Analytical Aspect

(M1030-02-11) Exploring the Use of Silicone-Based Microemulsions for Formulating Aesthetically Pleasing Topical Pharmaceuticals: Enhancing Patient Compliance and Product Aesthetics

(W1030-02-11) Injectable and Sustained Release Delivery System of Capsaicin-Loaded PLGA-Based In Situ Forming Implant for Treating Obesity: Characterization, Drug Release, and Stability Studies

(T1030-02-12) Nanoparticle in Rapidly Soluble Vaginal Film: A Promising Formulation for Pre-exposure Prophylaxis of HIV

(M1030-02-13) Prediction and Investigation of the Effect of Binders on the Occurrence of Tablet Sticking by Powder Rheology

(M1030-02-14) A Novel Self-Crosslinkable Hydrogel-Based Matrix Microneedle Patch for Smart Glucagon Delivery

(W1030-03-16) Preparation of ZnO Nanoparticles/Doxorubicin Loaded PLLA Nanofiberous Patch for Tissue Restoration and Immunotherapy in Breast Cancer

(M1030-03-17) Enhance Transport of Adenosine Integrated in Lipid Nanoparticles Crossing Reconstructed Human Epidermis

(T1030-03-17) Optimized and Scalable LNP Composition for RNA Vaccine Delivery

(W1030-03-18) Effect of Phospholipase A₂(PLA₂) Enzyme on Temozolomide Release from Composite Nanovesicles

(M1030-03-18) Formulation of Omeprazole Minitablets with Delayed Release: A Seal and Enteric Polymer Coating Approach

(T1030-03-18) Solubility Measurement and Modeling of Bisacodyl in Mono Solvent and Binary Solvent Mixture, and Its Application for Pharmaceutical Industry

(M1030-03-19) A Complex Bitter Tale of In Vitro vs. In Vivo Findings

(T1030-03-19) Influence of Key Formulation Factors in Oral Thin Film – Part 2 (Polyethylene Oxide)

(W1030-03-19) Preformulation Study of Poloxamer 407 Formulations for Otic Delivery: The Effect Ear Stimulating Fluid (ESF) and Some Salts on Gelation Characteristics

(M1030-03-20) CBD Solid Dispersion by Spray Drying

(T1030-03-20) Material Deformation or Material Hardness or Both: Tool for Predicting Tabletability Performance

(W1030-03-20) Predicting Drug Dissolution Performance Using Molecular Dynamics Simulations

(W1030-03-21) Development and In Vitro Evaluation of Eudragit-Coated Hot-Melt Extruded Ketoprofen-Pectin Pellets for Colon Targeting

(M1030-03-21) Exploring the Potential of Polyvinyl Acetate Dispersion and PVP-90 to Prevent Alcohol-Induced Dose Dumping in Modified Release Formulations

(T1030-03-21) Injection-Molded Coamorphous Tablets: Analysis of Intermolecular Interaction and Crystallization Propensity

(T1030-11-70) Amorphous Solid Dispersions of Cinnarizine – The Influence of Polymer Type and Manufacturing Method on Drug Solubility, Partition Coefficient and Stability

(W1030-11-70) Biodegradable Cationic Nanoparticles Prepared with Methylmethacrylate Copolymers Derivatives for Immune Activation and Cancer Immunotherapy

(T1030-11-71) Development of a Skin Patch of Baclofen for Sustained Management of Multiple Sclerosis Associated Spasticity

(M1030-11-71) Dual Functionalized Polymeric Nanoparticles Encapsulating Emtricitabine and Bictegravir for Delivery Across the Blood Brain Barrier for the Management of HIV Associated Neurocognitive Disorders (HAND)

(T1030-11-72) Enhancing the Oral Bioavailability of a Novel Anti-tuberculosis Drug Candidate, Quabodepistat, via Cocrystallization and Mechanistic Analysis of Differences in Bioavailability between Two Cocrystals

(W1030-11-72) Formulation and Evaluation of Carvedilol Loaded Niosomes Encapsulated in Polymeric Microneedle

(T1030-11-73) Industry Understanding for Overcoming Challenges to Demonstrate IVPT Sensitivity by Dose Amount and Dose Duration Modulation as per FDA Draft Guidance for Topical Drug Products

(W1030-11-73) Investigation of a Ternary Amorphous Solid Dispersion via Confocal Raman Spectroscopy: Where Is the Drug?

(M1030-11-73) Manufacturing and Elucidating the Drug Release Mechanisms of Long-Acting Ethylene Vinyl Acetate-Based Implants

(T1030-11-74) MRI Imaging of SLS 3D Printed Tablets in the Gastrointestinal Tract of Humans

(T1030-11-75) Simplified Formulation of Dietary Supplements Using High Functionality Clean Label Excipients – Case Studies

(M1030-11-75) The Impacts of PLGA’s Material Characteristics on the Performance of PLGA-Based Implant Prepared by Hot Melt Extrusion

(M1030-11-76) Correlation between Material Properties, Extrusion Processing Conditions and Permeability of Etonogestrel in Polyethylene Vinyl Acetate Films

(T1030-11-76) The Physicochemical Properties and Morphological Changes of PLGA-PEG Nanoparticles During Long-Term In Vitro Release

(M1030-12-78) Hydrolysis Kinetics of the Prodrug Dodecyl Nicotinate in Buffered Solutions, and Skin and Liver Homogenates

(W1030-12-78) Preparation of Propolis Extract and Its In Vitro Bioactivity Enhancement by Encapsulation

(T1030-12-79) Extrusion of Customized PLLA Filaments Reinforced with Zinc Oxide Nanoparticles for Fabrication of 3D Anti-tumor Printlets

(M1030-12-79) Improving Drug Solubility in Solid Oral Formulations Using Low Melting Point Systems

(W1030-12-79) In Vivo Evaluation of the Enteric Properties of Capsugel® Enprotect® Capsules in Fed State Conditions

(M1030-12-80) Enhanced Ocular Delivery of lifitegrast Using New Contact Lens DDS System

(W1030-12-80) Polymeric Excipient Selection and Their Role in Physically Stabilising Lumefantrine Amorphous Formulations

(T1030-12-80) Use of the Time–Temperature–Transformation Diagram to Evaluate the Role of Molecular Mobility on the Drug Stability in Amorphous Solid Dispersions

(M1030-12-81) Development of a Platform Coating Approach to Taste Masking Bitter Drugs in Micro-tablets for Pediatric Patients

(W1030-12-81) Structure-Functionality Relationship (SFR) of HPC for Solubility Enhancement: Importance of DS and MS for the HPC Hydration in Aqueous Solutions

(T1030-12-82) A Novel Binder Designed to Enable Widespread Adoption of Twin Screw Melt Granulation (TSMG)

(M1030-12-82) Investigation of Rational Selection of Small Molecule Acids in pH-Independent Extended-Release Matrix Tablets of Weakly Basic Drugs

(W1030-12-82) Navigating Titanium Dioxide Free Coating Systems: Evaluating the Risk and Understanding the Alternatives

(M1030-12-83) Application of Hybrid Extracellular Vesicle-Liposome (EV-Lip) to Improve the Encapsulation Efficiency of Antiretroviral Drugs

(W1030-12-83) Developing Microspherical Celecoxib Amorphous Solid Dispersion Using Electrospraying for Dissolution Enhancement

(T1030-12-83) Preparation and Aerodynamic Performance Evaluation of PLGA Microparticle with Dimple Surface

(M1130-01-01) Repurposing Neratinib for the Treatment of Triple-Negative Breast Cancer by Nanocrystals Formulation Approach

(M1130-01-02) Development of Therapeutic Immunoliposome to Deliver Recombinant Human Enzyme for the Treatment of Pompe Disease

(W1130-01-02) Itraconazole Concentrations in the Colloidal Aqueous Phase of Contents of Upper Small Intestine after the Standard High-Calorie High-Fat Meal and Their Relevance to Itraconazole Plasma Levels

(T1130-01-03) Evaluating the Versatility of the New High Molecular Weight HPC in Dual Active Diabetic Controlled Release Dosages

(W1130-01-03) The Development of Extended-Release and Mucoadhesive Buccal Films of Adipic Acid by Hot-Melt Extrusion for Long-Term Relief of Xerostomia

(T1130-01-04) Novel Abuse-Deterrent Tablet to Combat Opioid Abuse: A Hot Melt Extrusion Approach

(W1130-01-06) Development and Characterization of Ciprofloxacin Nanoemulsion-Loaded Bigels of Different Oleogel to Hydrogel Ratios: A Comparative Study

(M1130-01-06) Formulation and In Vitro Anticancer Activity of Folate Receptor Targeted PLGA Nanoparticles Loaded with Apigenin

(W1130-02-08) Colestipol Hydrochloride Tablets: Challenges of Formulating a Complex Active Pharmaceutical Ingredient and Product Quality Considerations

(M1130-02-08) The Development and Characterization of Nanocrystal-Loaded Dissolving Microarray Patches for Transdermal Atorvastatin Delivery

(M1130-02-09) Combining the Dynamic Gastric Model (DGM) with the Biorelevant Gastrointestinal Transfer (BioGIT) System to Evaluate the Performance of Three Nurofen® Ibuprofen Products

(T1130-02-09) Design of Hyaluronic Acid-Coated Nanoliposomes for Active Targeting of Ibrutinib

(W1130-02-09) Development of Polymeric Nanoparticles for Targeted Follicular Delivery of Tazarotene for Treatment of Inflammatory Skin Conditions

(M1130-02-10) Effect of Binary vs Ternary Systems on Stability and Drug Release Performance of Amorphous Solid Dispersions

(T1130-02-10) Enhancing Aqueous Solubility of BCS Class II Drugs Through a Dual Approach of Salt Formation and Amorphous Solid Dispersion

(W1130-02-10) Excipient Enhanced Growth (EEG) Synthetic Lung Surfactant Powder Formulation for Treating Neonatal Respiratory Distress Syndrome (NRDS)

(M1130-02-11) Extended Release Abuse Deterrent Formulation of an Opioid Analgesic

(T1130-02-11) Formulation Development and Characterization of Dual Drug Loaded Hot-Melt Extruded Inserts for Better Ocular Therapeutic Outcomes: Sulfacetamide/Prednisolone

(M1130-02-12) Machine Learning Predicts Pharmaceutical Inkjet Printing Outcomes

(T1130-02-12) Nitric Oxide Releasing Albumin Nanoclusters for Treating Methicillin-Resistant staphylococcus aureus Infected Cutaneous Wound

(T1130-02-13) Rapid Production of Personalized Medicines Using Tomographic Volumetric 3D Printing

(M1130-02-14) The Effect of the Edge Activator Combinations in Transethosomal Formulations for Skin Delivery of Thymoquinone

(W1130-03-16) Design, Physicochemical Characterization and In Vitro Cytotoxicity of Cisplatin-Loaded PEGylated Chitosan Injectable Nano / Sub-micron Crystals

(W1130-03-17) Effect of Bioadhesive Polymer Hydration on Mucociliary Clearance

(T1130-03-17) Transcytosis Mediated Deep Tumor Penetration for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer

(T1130-03-18) Bioequivalence Deficiencies Observed in Sucralfate Oral Suspension Generic Applications: An In-Depth Analysis of the Deficiencies Identified to Help Improve the Quality of Future Submissions

(W1130-03-18) Formulation and Development of Rivastigmine tartrate Sustained-Release Tablets

(M1130-03-18) Toward IVIVC for ASDs by Convolution of First Derivative Permeation Profiles

(M1130-03-19) Improving Bioavailability of Palbociclib Using Amorphous Solid Dispersion

(W1130-03-19) Optimization of Process Parameters for Apixaban Long-Acting Parental PLGA Microspheres

(W1130-03-20) Additive Manufacturing via Laser Sintering: Assessing the Influence of Parameter Selection on Printing Performance

(T1130-03-20) Fast Tablet Hard Coating with Xylitol

(M1130-03-20) The Role of MicroCoat™ in Refining Tamoxifen Administration to Mice and Achieving Inducible Cre Recombinase

(M1130-03-21) Is the pH-LLPS Concentration Profiles follow the Henderson-Hasselbalch Equation?

(W1130-03-21) Perforated Pan Coating of Directly Compressed Minitablets with the Use of Multi-tip Tooling to Facilitate Multi-particulate Drug Delivery: Challenges and Outcomes

(T1130-03-21) Use of High-Pressure Homogenization to Prepare a Nano-suspension for Intravenous Administration

(M1130-11-70) A DoE Approach to Study the Influence of TSWG Process Parameters on the Characteristics of Granules and Tablets

(T1130-11-70) Application of Colloidal MCC and Xanthan in Challenging Suspension Formulation

(W1130-11-70) Fabrication of Suppository Shells via Hot-Melt Extrusion Paired with Fused Deposition Modeling (FDM) 3D Printing Techniques

(M1130-11-71) A Kupffer Cell-Targeting Nanoparticle System to Mitigate Alcohol-Related Liver Disease (ALD)

(W1130-11-71) Characterization of 3D Printable Hydrogel-Inks for Cardiovascular Implants

(T1130-11-72) Estimation of Drug Apparent Solubility in Gastric Contents after the Standard High-Calorie High-Fat Meal: Comparison of Data in Biorelevant Media with Data in Aspirates

(W1130-11-72) Formulation Development and Evaluation of Cannabidiol Hot Melt Extruded Solid Self-Emulsifying Drug Delivery System for Oral Applications

(M1130-11-73) Hydroxypropyl-β-cyclodextrin (HPBCD) in Insoluble Drug-Loaded Nanoparticles Dissolution Studying: A New Approach to Overcoming Sink Limitations

(T1130-11-73) Influence of Drug Load and Surfactant Concentration on the Release Performance of Ternary Amorphous Solid Dispersions

(M1130-11-74) Manufacturing of Medicated Contact Lenses Using Inkjet Printing

(T1130-11-74) Multi-targeted Nanomedicine with Synergistic Doxorubicin and Oligo Hyaluronic Acid for Enhancing Anti-tumor Immunity in the Metastatic Triple-Negative Breast Cancer

(W1130-11-74) Pre-clinical and Clinical Evaluation of a Weekly Donepezil Transdermal Patch

(M1130-11-75) Radiation-Induced Tumor Penetration of Mesoporous Silica Nanoparticles for Enhanced Treatment of Ovarian Cancer Peritoneal Metastasis

(T1130-11-75) Sonoprecipitation Synthesis of a Multifunctional Prodrug Nanosuspension Using a Quality by Design Approach

(M1130-12-78) Mechanistic Insights of Luteolin Loaded Elastic Liposomes for Transdermal Delivery: HSPiP Predictive Parameters and Instrumental Based Evidence

(T1130-12-78) Particle Engineering of Large Surface Area, Low Bulk Density, High Drug Load Particles of Poorly Water-Soluble Drugs for Depot Delivery at the Site of Disease

(W1130-12-78) Unlocking Residuals: Shelf-Life Predication for Oral Tablets Using Moisture-Modified Arrhenius Modeling

(T1130-12-79) Development of Calcium Silicate Film-Coated Tablet as a Coloring Agent

(W1130-12-79) Personalisation of Data Matrix Encoded Hydrocortisone Orodispersible Films Using Inkjet Printing

(M1130-12-79) Use of Resonant Acoustic Technology for Ultra-Low Dose Blending in a Single-Step Mixing Process

(W1130-12-80) Effect of Particle Size on the In Vitro/In Vivo Evaluation of Long-Acting Injectable Paliperidone Palmitate Suspension

(T1130-12-80) Hot-Melt Extrusion of Simvastatin-Based Amorphous Solid Dispersions with PVP-VA and HPMC-AS

(M1130-12-80) Preparation and Characterization of Alectinib Amorphous Solid Dispersion Using a Novel Polymer Apinovex™ to Enhance Solubility and Dissolution

(W1130-12-81) Curcumin Nanocrystals-in-Nanofibers as a Promising Platform for the Management of Periodontal Disease

(M1130-12-81) Detection of Voriconazole Nanoaggregates in Rat Lung by Mass Spectrometry Imaging after Dry Powder Insufflation

(T1130-12-81) Lipophilic Copper Complex for Local Controlled Release of Nitric Oxide from Circulating Nitrites and S-nitrosothiols

(W1130-12-82) Mechanistic Modeling of Intramuscular Administration of Long-Acting Injectable Suspensions Accounting for Fibrosis at the Depot Site

(M1130-12-82) PVA as Binder in Continuous Twin-Screw Granulation

(T1130-12-82) Quality by Design (QbD) Based Formulation and Process Optimization for a Direct Blend Process: A Risk Based Industrial Approach

(M1130-12-83) A Data Based Approach to Selection of Bioavailability Enhancement Strategy Using New Simultaneous Dissolution-Flow Through Permeability for Formulation Development

(T1130-12-83) Exploration of Synergistic Polymer Combinations for Ocular Drug Delivery

(W1130-12-83) Exploring the Mechanism of Mechanochemically Induced Cocrystal Formation with Terahertz Spectroscopy

(M1230-01-02) Formulation Development and Evaluation of Cannabidiol Oral Film Using Antisolvent and Solvent Casting Approaches

(W1230-01-02) Liposome-Based Dissolving Microneedles Loaded with Rifampicin for Improved Treatment of MRSA-Induced Skin Infection

(M1230-01-03) Characterization of Drug Release from a Blended Biodegradable Polymeric Film Using a Central Composite Design

(T1230-01-03) Novel Expandable Platform for Retentive Drug Delivery Systems

(W1230-01-04) Development of a Novel Polymeric Composite Film and Elucidation of Its New Alcohol-Resistant Mechanisms for the Prevention of Alcohol-Induced Dose Dumping

(T1230-01-04) Evaluation of Critical Quality Attributes (CQA’s) of Carbomer Based Topical Hydro Gels with Process Analytical Technique (PAT)

(W1230-01-05) Brain Targeted Delivery of Cannabidiol and Brain Derived Neurotrophic Factor (BDNF) for Attenuation of Inflammation and Promotion of Neurogenesis for the Management of Alzheimer’s disease

(M1230-01-05) Mechanistic Analysis of Excessive Viscosity Increase of Drug Nanosuspension during Wet Milling

(W1230-01-06) Fibronectin-Targeted Dendron Micelles to Effectively Deliver BRD4-Inhibitors for Inflammation Reduction in an Idiopathic Pulmonary Fibrosis Model

(M1230-01-06) Screening of Synergistic Combination of Ferroptosis-Inducing Drugs and Development of Targeted PLGA Nanoparticles for Improved Anti-Cancer Therapy

(M1230-01-07) Does Elastomer QbD Approach Benefit the E&L Risk Profile for Drug Compatibility? A Comparative Leachables Simulation Study at 12M for Stoppers

(M1230-02-08) A Quality-by-Design Approach for the Development of Inhalable Dry Powder Containing Dual Drug-Loaded Polymeric Nanoparticles for Pulmonary Tuberculosis Treatment

(T1230-02-08) Application of Ac-Di-Sol® SD-711 in Orally Disintegrating Tables (ODTs): Performance Comparison of Croscarmellose Sodium and Crospovidone

(W1230-02-08) Colorectal Lumen-to-Tumor Delivery of Rectally Administered Ligand-Functionalized Nanoparticles for the Local Treatment of Colorectal Cancer

(M1230-02-09) Comparison of Controlled-Release Performance between Carrageenan and Several Other Hydrophilic Polymers

(W1230-02-09) Development of Rapidly Soluble Mebendazole Nanosuspension for Colorectal Cancer

(T1230-02-10) Evaluating the Dissolution of Commercially Available Metered Dose Inhaler (MDI) Drug Products from Realistic In Vitro Experiments

(W1230-02-10) Exploring Dual Centrifuge Wet Media Milling Process as an Organic Solvent Free Method to Prepare Liposomes with High Drug Loading

(T1230-02-11) Formulation Development and In-Use Sprinkle-on-the-Food Stability of Delayed-Release Pellets in Capsules: A Case Study

(M1230-02-12) Management of Type-2 Diabetes via Exploration of Transdermal Delivery Strategies for Linagliptin

(T1230-02-12) Non-haemolytic Nanoemulsions Development and Characterization for Novel Anti-prostate Cancer Compound PC257

(W1230-02-12) Polymorphism and Solvatomorphism of Niclosamide-Camostat Cocrystals and Bioavailability Enhancement of Low-Solubility API via Co-Crystallization

(M1230-02-13) Preparation and Evaluation of Co-Amorphous Formulations of Telmisartan - Amino Acids as a Potential Method for Solubility and Dissolution Enhancement

(W1230-02-13) Studying Drug Release in Multilayered Polymer-Drug Formulations for Oral Delivery

(M1230-02-14) The Influence of Coating Parameters on Transparency of Semi-permeable Membrane Coating of Push-Pull Osmotic Pump Tablets

(T1230-03-17) FDM 3D Printing Tablets Containing Iron Oxide Nanoparticles to Treat Iron Deficiency

(W1230-03-17) Minoxidil Foaming Topical Formulation without Propellant and Inhibition of Crystalline Formation

(M1230-03-17) Strategies for Producing Clinical and Commercial RNA-LNP Drug Products

(T1230-03-18) Application of Hot Melt Extrusion Technology for the Preparation of Carbamazepine Extended-Release Tablets

(M1230-03-18) Formulation of an Inhalable Nanoemulsion Prepared with a Deep Eutectic Solvent of Pirfenidone and Citric Acid

(W1230-03-18) Stimuli-Responsive Newly Designed Poly (amino ether) Glycopolymer Based Pegylated Nanoparticles Conjugated with Receptor Binding Peptide for siRNA Delivery to Treat Lung Cancer

(W1230-03-19) Characteristic and Bio-Functionality of a Novel Multilayered Crosslinked Nanoscaffold for Tuberculosis Granuloma Modelling

(M1230-03-19) Preparation of Osmotic Tablets Using a Direct-to-Hopper Formulated Push Layer Based on Polyethylene Oxide

(W1230-03-20) Development of a Novel, Semi-mechanistic In Vitro Dissolution Model to Inform Physiology-Based Biopharmaceutics Modeling Frameworks

(T1230-03-20) Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids

(M1230-03-20) Drug Product Attributes as an Effect of Formulation Composition of Vardenafil HCl Tablets Produced by the Mixture of the Coprocessed Excipient versus a Similar Spray-Dried Lactose Blend

(T1230-03-21) Applicability of Ryshkewitch-Duckworth Based Models to Predict the Tensile Strength of Compacted Mixtures

(W1230-03-21) Fabrication of Bio-Adhesive Gastric Floating Pellets Using Hot-Melt Extrusion

(M1230-03-21) Should Amorphous Dispersions Always Be Used as a Formulation Development Strategy?

(M1230-11-70) A Nature Inspired Octopus-Shaped 3D Printed Floating Drug Delivery System

(T1230-11-70) Application of Physiologically Based Pharmacokinetic Modeling to the Prediction of In Vitro and In Vivo Permeation of the UV Filter Octocrylene

(W1230-11-70) Characterization of a New Multifunctional Disintegrant for Continuous Manufacturing

(M1230-11-71) Design and Development of Nanoformulation of GMC1, a Novel Agent for the Treatment of Castration Resistant Prostate Cancer

(T1230-11-71) Development of Cannabidiol-Loaded Nanostructured Lipid Carriers as an Approach for Potential Solubility Enhancement

(M1230-11-72) Encapsulation of Zidovudine via Spray-Drying for Taste-Masking for Incorporation into an Orally Dispersible Film

(T1230-11-72) Evaluation of Developmental TiO2 Free High Productivity and High Opacity Coating System at Different Scales

(W1230-11-72) Formulation Development of Programmable Drug Delivery Multi-Unit Systems for the Delayed and Extended Release of Fixed Dose Combination Drugs

(M1230-11-73) Impact of Clean Label Lubricant Inclusion Level and Mixing Time on Tablet Properties

(T1230-11-73) Injectable Antibacterial Dressings for the Prevention of Bacterial Biofilm in Chronic Rhinosinusitis (CRS)

(M1230-11-74) Mass Transport Analysis of Solute Transport through Lipophilic Membranes

(M1230-11-75) Rational Development of Fingolimod-Curcumin Nanosuspension as a Potential Intranasal Neuroprotective Therapy after Ischemic Stroke

(T1230-11-75) Spray Drying (SD) and Hot Melt Extrusion (HME) for the Preparation of Amorphous Solid Dispersions (ASDs)

(T1230-11-76) Calcium Carbonate as an Alternative to Titanium Dioxide in Coating: The Importance of Particle Engineering

(M1230-11-76) Topical Ocular Administration of Hydrogen Sulfide Donor: Assessment of Permeability through Isolated Bovine Cornea Ex Vivo

(M1230-12-79) Characterization and Performance of 60% Drug Loaded Freeze-Dried Amorphous Nanoparticle Tablet of a BCS IV Compound: ABT-530

(T1230-12-79) P188 – Polymeric Carrier for Solid Dispersion Enabling Formulations of PROTACs

(T1230-12-80) Calorimetric Investigation on the Disintegration Process of Pharmaceutical Tablets

(M1230-12-80) Formulation Development and Characterization of Parenteral Nicardipine HCl Product for Intrathecal Administration

(M1230-12-81) Ciprofloxacin-Loaded Albumin Nanoparticles as a New Strategy for the Treatment of Urinary Tract Infections and Catheter-Associated Urinary Tract Infections

(T1230-12-81) Development of a Fixed-Dose Combination Using Concurrent Twin-Screw Hot Melt Extrusion and Melt Granulation: Optimization of Polymer-Diluent Combinations for Enhanced Drug Delivery

(T1230-12-82) Evaluation of Polymeric Excipients for Stabilization of High Drug Loaded Solid Dispersions of Itraconazole

(M1230-12-82) Impact of Extra Components Added to an All-in-One Coprocessed Excipient to Obtain a Better Processability of Cohesive and Poor Flowing Hydrochlorothiazide

(T1230-12-83) In Vivo Studies of Letrozole Non-aqueous Nano Emulgel Transdermal Delivery Systems

(M1330-01-02) Drug Crystal Growth Rate Decreases in the Presence of Coexistent Drug-Polymer Halogen and Hydrogen Bonds

(M1330-01-03) Formulation Testing of TiO2-Free Film Coating Alternatives from Three Film Coat Vendors

(T1330-01-03) Increasing Oxidative Stability with High Purity Excipients Used in Ophthalmic Formulations

(M1330-01-04) Characterizing the Drug Gastrointestinal Transfer Process after Disintegration of Solid Dose Units in the Fed State

(T1330-01-04) Demonstrating the Utility of a New High Molecular Weight HPC to Make Smaller Modified Release Tablets

(T1330-01-05) Evaluation of the Compatibility of Capsugel® Enprotect® Capsules with Solid Phase Excipients to Accelerate Developments of New Enteric Drug Products

(M1330-01-05) Mixing Differences during Preparation Methods have Implications on Successful Formation of Amorphous Solid Dispersions

(T1330-01-06) Statistical Optimization of Stable Quercetin Nanoparticles for Tumor Targeting

(M1330-01-07) Understanding the Relationship Between In Vitro Nasal Spray Characteristics and Intranasal Deposition in the Adult and Pediatric Populations

(M1330-02-08) A Single-Step Extrusion Process for Formulation Development of Self-Emulsifying Granules for Oral Delivery of a BCS Class IV Drug

(M1330-02-09) Computational Prediction of Initial Dissolution Performance after Co-milling with PVP

(T1330-02-09) Development of 4-phenylbutyric Acid Microsponge Formulations as a Potential Antidote for Skin Injury Due to Chemical Warfare Agents

(T1330-02-10) Evaluating the Impact of an Ultra-High Solids Film Coating System on Process Times and Tablet Aesthetics

(M1330-02-11) Formulation and Characterization of Non-invasive Nebulization Based Antiviral Drug, NSF207 Loaded Pegylated Nanoliposomal Suspension Product for Treatment of COVID-19

(T1330-02-11) Formulation of Cocrystal and Amorphous Solid Dispersion Printlets Developed by Hot Melt Extrusion Paired Fused Deposition Modeling for Dissolution Enhancement andStability of Ibuprofen

(M1330-02-13) Preparation and Optimization of Piperine Nanoparticles for Its Intranasal Delivery

(T1330-03-17) Development of Hydroxypropyl Methylcellulose (HPMC)-Based, Titanium Dioxide (TiO₂)-Free Coating

(M1330-03-17) Performance Evaluation of Different Diluents for the Direct Compression of Acetaminophen Tablets

(M1330-03-18) Crafting Lipid-Polymer Nanoparticles of HDAC Inhibitors for the Treatment of Retinitis Pigmentosa

(T1330-03-18) Equilibrium Solubility, Thermodynamic Modeling and Solubility Parameters of Itraconazole in Solvent Mixtures at Various Temperatures

(M1330-03-19) A New Solid Dispersion Modelling Framework for In Vitro and In Vivo Oral Absorption Anticipation Adapted to pH-Sensitive Matrices

(T1330-03-19) Using Biorelevant Dissolution to Better Predict Bioavailability Issues

(M1330-03-20) Development of Various Formulation Strategies/Approaches for an Extended Release of a Non-opioid Narcotic for the Treatment of Acute/Chronic Pain

(T1330-03-20) Orally Disintegrating Tablet Formulation of Vardenafil Taste-Masked Pellets

(M1330-03-21) Developing Degradable Microparticles for the Delivery of Inactivated H1N1 Virus and NKT Cell Agonist for Single Dose Vaccination

(T1330-03-21) Quantitating the Contributions of the Particle Drift Effect to In Vitro FLUX and the Application of Particle Drift Flux to Predictive Modelling

(T1330-11-70) Are Globally Marketed Generic 1% Clotrimazole Creams Pharmaceutically Equivalent?

(M1330-11-71) Design and Evaluation of Colon-Targeted Dexamethasone Solid Dispersions for Inflammatory Bowel Disease

(T1330-11-71) Development of Hot-Melt Extruded Solid Self-Nanoemulsifying Drug Delivery System for Improved Oral Delivery of Poorly Water-Soluble Drug Using Central Composite Design

(M1330-11-72) Engineering Gefitinib-Loaded Inhalable Solid Lipid Nanoparticles Using an Organic Solvent-Free Homogenization Method for the Treatment of Non-small Cell Lung Cancer

(M1330-11-73) Impact of Core Excipient Selection to Improve the Stability of a Moisture Sensitive Drug, Acetylsalicylic Acid

(T1330-11-73) Investigating and Optimizing the Influence of Process Parameters on Development of Polymeric Microparticles: A Quality-by-Design Approach

(M1330-11-74) Mechanism and Generality of the Tabletability Flip Phenomenon

(T1330-11-74) Novel LAAM Immediate Release Capsule for Treating Opioid Use Disorder

(T1330-11-75) Stabilizing High Salt Content Suspensions with Colloidal Microcrystalline Cellulose and Xanthan

(T1330-11-76) Development of an Iontophoresis-Coupled Microneedle Skin Patch of Naloxone for Emergency Treatment of Opioid Overdose

(M1330-12-78) A Novel Approach for Targeted Pulmonary Delivery of Thymoquinone as Dry Powder Inhaler (DPI)

(T1330-12-78) Thermally Gelling Hypromellose Liquid Sprays for Oropharyngeal Targeting

(T1330-12-79) Sweet Levofloxacin Acesulfame Crystals with Improved Compaction Property and Solvates Interconversion

(M1330-12-80) Development of a Novel Therapeutic Contact Lens with the Embedded-Drug Chamber as an Ophthalmic Drug Delivery System for Dry Eye Syndrome

(T1330-12-80) Surfactant Selection in the Development of Oral Ternary Amorphous Solid Dispersions from the Perspective of Solubility and Supersaturation

(M1330-12-81) Development of Nanofiber-Based, Anti-proliferative Sutures for Glaucoma Surgery

(T1330-12-82) Formulation and In Vitro Characterization of Orally Disintegrating Tablets of Drug Molecules with Varied Physicochemical Properties

(M1330-12-82) Unlocking the Potential of Co-processed Excipient and algorithm-based tool for Direct Compression Tablet Manufacturing

(M1330-12-83) Physical Stability of Amorphous Pharmaceutical Formulations Insights into Crystallization Behavior

(T1330-12-83) Role of Polymers in the Physical and Chemical Stability of Amorphous Solid Dispersion: A Case Study of Carbamazepine

(T1430-01-02) Design and Development of High Drug Loading Commercial Formulation for a Salt Drug Substance with High Propensity of Solid Form Conversion

(M1430-01-03) Fusogenic Liposomes as an Approach to Enhance the Efficacy of Antimicrobials

(M1430-01-04) Shear-Induced Crystallization of Amorphous Indomethacin

(M1430-01-05) Cisplatin-Loaded Dendritic Mesoporous Silica Nanoparticles for Improved Drug Delivery to Ovarian Cancer Metastasis

(T1430-01-05) Influence of Kollicream^® OD on Ibuprofen Skin Permeation and Retention

(T1430-01-06) Systematic Screening of Pharmaceutical Co-crystals Using Experimental and Computational Tools

(M1430-01-07) A Novel Octreotide Conjugated PEGylated Liposomal Paclitaxel for Targeted Pancreatic Cancer Treatment

(T1430-02-08) Bioadhesive and Sustained Release Epinephrine-Loaded Sodium Alginate Hydrogel Accelerates Hemostasis to Manage Gastrointestinal Bleeding

(M1430-02-09) Co-solvents for Microemulsion Formulations containing Ethoxylated Castor Oils for Transdermal Drug Delivery

(T1430-02-09) Development of a Hollow Vaginal Drug-Eluting Device Using Stereolithography 3D Printing for the Treatment of Recurrent Vulvovaginal Candidiasis

(M1430-02-11) Formulation and Evaluation of Prochlorperazine Maleate Sustained Release Mucoadhesive Buccal Films Using Hot Melt Extrusion

(M1430-02-12) Microfluidics Generated Aspirin Loaded Albumin Nanoparticles for Targeted Brain Delivery in the Treatment of Ischemic Stroke

(T1430-02-12) Novel Melting Point Depression Method to Predict Drug Dissolution during Melt Extrusion of PLGA Millifiber Implant

(M1430-02-13) Preparation of Ketoprofen Polymer Based Solid SEDDS Using Twin Screw Melt Granulation to Improve the Solubility and Permeability

(T1430-02-13) Roles of Protein Corona in Physicochemical Properties and Stability of pH-Triggering Self-Assembled Nanoparticles of Drug-Myristic Acid Conjugate

(M1430-02-14) Transdermal Delivery of Cannabidiol from Marketed Cannabidiol Patches

(T1430-03-15) Beyond Conventional Boundaries: New Excipients for ASD Formulation

(M1430-03-17) Optimizing Microfluidic Process Parameters and Lipid-Cholesterol Composition for Lysozyme-Loaded Liposome Preparation

(T1430-03-17) Preparation and Evaluation of Temozolomide Solid Lipid Nanoparticles: Focus on Improvement in Bioavailability and Physiochemical Analysis for Decreased Toxic Effect in Glioblastoma Multiforme

(T1430-03-18) Dual Drug-Loaded Cubosome Nanoparticles for Pulmonary Tuberculosis Treatment

(M1430-03-18) Volumetric Printing and Non-destructive Dose Verification of Water-Soluble Vat Photopolymerized Tablets Based on Supramolecular Chemistry

(M1430-03-19) Antimicrobial and Angiogenic Silver Nanoparticles and Verapamil Double-Layered Electrospun/3D Printed Wound Healing Patch for Accelerated Wound Healing

(T1430-03-19) Levofloxacin, a Complex Fluoroquinolone Drug and Its Organic Solvent-Free Journey to Amorphization

(M1430-03-20) Mini Tablets as a Compliant and Flexible Pediatrics Delivery System

(T1430-03-20) The Impact of Particle Size of the Drug Substance on Dissolution of Finished Product for the Treatment of Cushing’s Disease in Dogs

(M1430-03-21) Computational Support to Identify Ternary Solid Dispersions of Hydroxypropyl Cellulose and Small Molecular Additives to Stabilize Challenging Drugs

(T1430-03-21) Phase Transitions and Apparent Acidity in HSA/Saline Solution during Freezing and Post Freeze-Drying

(M1430-11-70) A Strategy for Optimizing Precompression Pressure Using In-Die Elastic Recovery

(T1430-11-70) Assessing the Impact of Dry Particle Coating with Nano-Silica on Compaction Properties of Cohesive Active Pharmaceutical Ingredients

(T1430-11-71) Development of Hydrogel Polymer-Based Bilayer Gastro-Retentive Modified-Release Tablets

(T1430-11-72) Evaluation of Stability and Physical Parameters of Sitagliptin IR Tablets Coated with Different Titanium Dioxide Free Coating Systems

(M1430-11-74) Mechanism of Stabilization of Amorphous Solid Dispersion above the Overlap Concentration (c*): Delay of the First Nucleation Event

(T1430-11-74) Novel NanoSensoGel Engineered for Prevention of Chemotherapeutic-Induced Ototoxicity and Associated Hearing Loss

(M1430-11-75) Rizatriptan Nasal Spray with Effective Olfactory Deposition for Improving Migraine Treatment

(T1430-11-75) Suitability of Isavuconazonium Sulfate as a Biopharmaceutics Classification System (BCS)-Based Biowaiver Candidate

(M1430-11-76) Understanding the Impact of Accelerated Release Testing Conditions on Transport Properties and Release Mechanisms of Drug from Long-Acting Ethylene Vinyl Acetate Implants

(M1430-12-78) Investigating the Effect of Plasticizer Type and Concentration on Kollicoat® SR Films Prepared by Film Casting Technique

(T1430-12-78) Preliminary Study of How Capsule Materials Influence the Physical Stability of Dried Powder Inhalers

(M1430-12-79) Gatifloxacin Nanoemulsions Prepared by Hot Melt Extrusion/Hot-Homogenization for Bacterial Conjunctivitis.

(T1430-12-79) Improving Oral Absorption of Rapidly Crystallizing Parent API Using Prodrug Strategy: Comparison of Phosphate Versus Glycine Based Prodrugs

(T1430-12-80) Development and Application of USP Apparatus 3 for In Vitro Drug Release from a Paclitaxel Nanocrystal Formulation

(M1430-12-80) Encapsulation in Glucan Particles Promotes Solubility and Anti-biofilm Activity of Natural Poly-actives In-vitro

(M1430-12-81) Formulation, Optimization, and In Vitro Studies of Atorvastatin Calcium Cocrystals

(T1430-12-81) Novel High Throughput Polymer Screening for Development of Amorphous Solid Dispersion

(M1430-12-82) Aceclofenac-Loaded Nanoparticulate Carriers with Enhanced Solubilization Using Deep Eutectic Solvents for Improved Transdermal Delivery

(T1430-12-82) Personalized 3D Printing Earring Tap for Treating Affections Caused by Aesthetic Perforations

(M1430-12-83) Common Deficiencies Using Alternative Bioequivalence Approach for Metered Dose Inhaler in Abbreviated New Drug Applications

(T1430-12-83) Design of a Re-Dispersible High Drug Load Amorphous ABT-530 Formulation: Impact of Formulation Composition on Processing and Performance

(T1530-01-01) Application of Solid-State NMR and DSC in Evaluating the Effect of Intrinsic and Extrinsic Factors and Surface Energy of the 3D Printed Probe on Adhesion Properties of Transdermal Patches

(T1530-01-02) Exploring the Properties of Hexagonal Liquid Crystalline Nanoparticles for Co-delivery of Dexamethasone Acetate and siRNA TNF-α

(M1530-01-02) Simultaneous XRD-DSC Analysis Identifies Correct Solid Form Dissolution in Polymer

(M1530-01-03) Drug Nanocrystals Enable Rapid Formulation Transfer from Liquid-Phase Pre-clinical Testing to First-in-Human Solid Dosage Forms

(T1530-01-03) Influence of Polymer Miscibility on Drug Release from Microparticles Prepared Using a 3-Fluid Spray Drying Process

(T1530-01-04) Design of Experiment Multi-level Categoric Design Model for Formulation Parameters’ Optimization of Raloxifene Hydrochloride Solid Dispersion Produced by Hot-Melt Extrusion

(T1530-01-05) Personalized Polypill Using a New Flexible 3D Printed Design

(M1530-01-06) Combination Therapy of BRD4/PI3K Dual Inhibitor and Novel Tubulin Inhibitor Efficiently Treats Chemo-Resistant Pancreatic Cancer

(T1530-01-06) Targeted Combination Therapy for Pancreatic Cancer Management

(M1530-02-09) Design of Citric Acid Coated Superparamagnetic Iron Oxide Nanoparticles for the Treatment of Lung Cancer

(T1530-02-09) Development of a Stable Intravenous Injectable Formulation of Highly Hydrolytic Molecule in a Co-Crystal with a Highly Hydrophobic (A1) and Highly Hydrophilic (A2) Drug Substance

(M1530-02-10) Encapsulation of Cabazitaxel in Polymeric Nanoparticles and Its Biological Effect on Prostate Cancer Cells

(T1530-02-10) Evaluation of Stability of Ion Exchange Resin Based Carrageenan Gummies

(M1530-02-11) Formulation and Evaluation of Pulsatile Release Melatonin Capsule (Single and Multiple Unit Pellets) for Circadian Rhythm Sleep Disorders

(T1530-02-11) In Vivo Characterization and Bioequivalence Study of 3D Printed Tenofovir Disoproxil Fumarate Printlets

(M1530-02-12) Multiphysics Modeling and Experimental Design of Novel Ocular Drug Delivery Systems for Glaucoma Treatment

(T1530-02-12) Optimization of Spray-Drying Process Parameters for the Preparation of PVP Microparticles Suitable for Nose-to-Brain Drug Delivery

(M1530-02-13) Preparation of Nanoparticles Based on Krafft Point of Nonionic Polyoxyethylated Amphiphiles

(T1530-02-13) Scalability of EUDRATEC ^® Fasteric, an Advanced Technology to Target the Duodenum for Improved Absorption

(T1530-02-14) Application of Novel Supercritical Fluid Technology in Developing Albendazole Solid Dispersion

(T1530-03-15) Enhancing Oral Absorption of a Poorly Water Soluble Anticancer Drug via Prodrug Modification

(M1530-03-17) Improving Aerodynamic Performance with Spray-Dried Corrugated Chitosan Microparticles

(T1530-03-17) Preparation and Characterization of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Drug Delivery

(T1530-03-18) Application of Hypromellose Phthalate (HPMCP) for the development of Esomeprazole 20mg Multiple Unit Pellet System (MUPS)

(M1530-03-18) Understanding the Role of Particle Size of Poloxamer P407 on Properties of Tablet Prepared by Direct Compression Process

(M1530-03-19) Impact of Food on the Release and Bioaccessibility of an Oral BCS Class IV Compound formulated from Different Conventional and Enabling Formulations using the Dynamic Gastrointestinal Model Tiny-TIMsg

(M1530-03-20) Digestion Is a Critical Element for Absorption of Cinnarizine from Supersaturated Lipid-Based Type I Formulations

(T1530-03-20) Vial Containment Systems for Gene Therapy Drug Products

(T1530-03-21) A First-in-Human Assessment for TQS-168, Including Safety, Tolerability, Pharmacokinetics, Formulation Selection, and Food Effect in Healthy Volunteers

(M1530-03-21) Predicting the Relative in Vivo performance of Nanoformed and Crystalline Bulk Piroxicam Solid Suspensions from in Vitro Flux Measurements

(T1530-11-70) Assessing the Impacts of Drug Loading and Polymer Type on In Vitro Dissolution and Flux Behavior of GDC-A Amorphous Solid Dispersions

(M1530-11-71) Development of a Novel Repeat-Action Oral Drug Delivery System for Naproxen and Esomeprazole

(T1530-11-71) Development of Inhalable Inclusion Complexes of Poorly Water Soluble Crizotinib for Treatment of Non-small Cell Lung Cancer

(M1530-11-72) Enhanced Dissolution of Amphotericin B through Development of Amorphous Solid Dispersions Containing Polymer and Surfactants

(T1530-11-72) Evaluation of Supported-Liquid Extraction Technique and Matrix Effect in LCMS-MS Method Development of a Model Hydrophobic Drug

(M1530-11-73) Impact of Structural Relaxation in Amorphous Solid Dispersions

(T1530-11-73) Investigating the Relationship between Microstructural Properties and In Vitro Release Characteristics of PLGA Microspheres

(T1530-11-74) Optimizing the HME Process for Precise Manufacturing of Subcutaneous Drug Delivery Implants: Key Considerations for Quality and Efficiency

(M1530-11-75) Role of Citric Acid in Enhancing Drug Performance: A Double-Edged Sword?

(T1530-11-75) Suitable Powder Characteristics of ASDs for Direct Compression Obtained via Spray Drying

(T1530-11-76) Solubility Enhancement via Amorphous Solid Dispersions: Extended Functionality by Applying a Versatile Polyvinyl Alcohol Platform for Hot Melt Extrusion

(M1530-11-76) Understanding the Role of Water on the Molecular Mobility of Polymer Systems with Terahertz Spectroscopy

(M1530-12-77) Poloxamer 188 in Amorphous Solid Dispersions of Efavirenz and HPMC-AS Improves In Vitro Dissolution of the Drug but Does Not Affect In Vitro Permeation nor In Vivo Absorption

(T1530-12-78) Preclinical Evaluation of Brinzolamide Ophthalmic Suspensions with Variations in Critical Quality Attributes and Considerations for Pharmacokinetic/Pharmacodynamic Study Designs

(M1530-12-79) Development of Antibody Conjugated Nanoparticles for Delivery of Nucleic Acid for Stimulation of Perivascular Macrophages

(M1530-12-80) A New and Sustainable Twin Screw Wet Granulation Method Making Subsequent Drying Obsolete

(T1530-12-80) Elucidating the Mechanisms Underlying Enhanced Absorption in Rapidly Dissolving Amorphous Solid Dispersions

(T1530-12-81) Evaluating the Impact of Excipient Selection on Nitrosamine Formation in Drug Products

(M1530-12-81) Spatial Heterogeneity in Drug Crystallization in Extrudates Prepared by Hot Melt Extrusion

(T1530-12-82) Well Characterized Lipid Nanoparticle Library Accelerates Development of Next Generation Genomic Medicines

(T1530-12-83) Development of a Novel Lipid Nanoparticle Based Immunochemotherapy against Brain Cancer

(M1530-12-83) Effect of LNP Components on mRNA-Mediated Protein Expression of Lipid Nanoparticles in Different Organs

(M0930-02-10) Dissolving Microarray Patches Loaded with Atorvastatin Microparticles for Intradermal Long-Acting Delivery

(T0930-02-14) Improvement of Mechanical Properties of MRTX0902 by Crystalline Form Selection and Particle Engineering

(W0930-11-76) A Study to Assess the Gastro-Resistance and Dissolution Rate of Enteric Coated Not-Banded Gelatin and HPMC Capsules

(T1030-01-04) Solubility Enhancement of Atorvastatin Calcium Using Cyclodextrin

(T1130-11-76) Loading of Minoxidil to Extracellular Vesicles to Enhance the Transdermal Delivery to Hair Follicle

(W1230-11-71) Dissolving Microneedle Patches for Enhanced Melanoma Ferroptosis Therapy Based on a Lipophagy-Fueled Strategy

(M1230-12-78) Disruption of Octreotide Interactions with the Bile Acid-Phospholipid Mixed Micelles Using Bile Acid Sequestrants

(T1530-03-19) Utilization of Polymeric Micelles to Enhance Anticancer Activity through Combined Therapy with Luteolin and Doxorubicin

(T1530-12-79) Dissolution Technology Using HPMCAS Solid Dispersion Targeting the Upper Small Intestine

(M0930-08-49) Novel Strategies for Process-Related Impurity Clearance during Biologics Manufacturing

(T0930-09-56) Development of a High Purity, High Productivity Cell Culture Media Additive

(W0930-09-56) Potency Assay Development for Gene Therapy Products – Approaches and Points to Consider in Data Processing

(M0930-09-56) Reliable Sizing of Lipid Nanoparticles in Concentrated Formulations Using Advanced Dynamic Light Scattering

(M0930-09-57) Identification of Isomerization in IgG1 and Its Impact on Potency: Case Study of a Mab Biosimilar

(T0930-09-57) In-Depth Characterization of PS-80 Degradation in Biologics Drug Products by Reversed Phase Liquid Chromatography Coupled with Charge-Reduction High Resolution Mass Spectrometry

(M1030-08-50) Characterizing Protein Aggregation Using Flow Imaging Microscopy with Orthogonal and Complementary Analytical Techniques

(M1030-08-51) Automated In Vitro Population Bioequivalence for Inhaled Products to Meet the FDA Guidance on Budesonide Using Phoenix® WinNonlin®

(W1030-08-52) Advancing Nanocarrier Therapeutic Development with Structural AI Analysis of Cryo-EM Images

(T1030-08-52) Characterization of Host Cell Protein Impurity Coverage by a Process Specific Assay Kit for Its Suitability for Use during Late Phase Manufacturing of an Investigational Therapeutic Fc-Fusion Protein

(T1030-08-55) Biomolecule Characterization Using UV-Vis Spectroscopy: A Focus on Thermal Stability of Nucleic Acids and Proteins

(T1030-09-56) Cellular Uptake Mechanism of Hollow Polydopamine Nanoparticles, Nanosac

(M1030-09-56) Investigating In Vitro Transcription of Host Cell and Plasmid DNA Impurities in Recombinant AAV Drug Substances

(W1030-09-56) Peptide-Based-Solutions to Reduce Undesired Cell Culture Media Chemistry – New Options for Stabilized Media Formulations

(M1030-09-57) Measuring and Controlling Potency of a Targetless Biologic: Study of PEGylated Hemoglobin

(M1130-08-49) Identifying and Characterizing the Effect of Critical Processing Parameters in Double Emulsion Poly(lactic-co-glycolic) Acid Microparticle Fabrication

(M1130-08-50) A Multicomponent Media Analysis Workflow using Triple Quadrupole Mass Spectrometry during Human Primary T cell Culture

(W1130-08-53) Impact of Lyoprotectant Thermal Properties on Batch Heterogeneity through Various Processing Technologies: Annealing vs. Controlled Ice Nucleation

(M1130-09-56) Development of an Industry Ready Cell-Based Potency Method for an Oncolytic Virus Immunotherapy

(W1130-09-56) Investigating Stability of Trastuzumab (Herzuma^®) Undergoing Lyophilization and Freeze-Thaw Stresses

(T1130-09-57) High-Throughput Characterization of Gene Therapy Products by SEC-MAL

(M1130-09-57) Revisiting UV Spectroscopy for Real-Time Monitoring of Reversible Protein Unfolding

(T1230-08-49) Addressing the Challenges of Industrial Manufacturing of Lipid-Based Complex Injectables: Fine-Tuning of Membrane Fluidity Using Quality-by-Design as a Tool to Enhance Process Effectiveness

(T1230-08-52) LC and LCMS Solutions for Sample Preparation, and Data Analytics to Advance Oligonucleotide Therapy Development

(T1230-09-56) Encapsulation of Low Molecular Weight Chemokines via Single Emulsion Technique

(M1230-09-57) A Workflow for Purity Determination, Intact Mass Measurement, and MS/MS Sequencing of Oligonucleotide Impurities Detected in Synthetic Oligonucleotides

(M1230-09-58) Photo-Stability of Peptides Exposed to LED, Fluorescent or UV Light in Liquid and Solid Formulations

(T1330-08-49) Continuous Processing of Liposomal Nanoparticles as Potential Reference Materials for Drug Product Development

(M1330-08-49) CryoTEM Characterization of Vaccine Materials in Development

(T1330-09-56) In-Cell ELISA Assays to Assess Drug Relative Potency Using the Cytation Imaging Reader for Sample Analysis

(M1330-09-56) Lipid Nanoparticle Impurity Monitoring Using Single Quadrupole Mass Detection for Regulated Environments

(M1330-09-57) Unveiling the Impact of Surface Chemistry on Adsorption of a Therapeutic Monoclonal Antibody Using a Quartz Crystal Microbalance

(M1430-09-56) A Model-Based and Quality-by-Design Compatible Lyophilization Cycle Development Strategy for Biopharmaceuticals

(T1430-09-56) Using Experimentally Validated ML Modeling to Predict the Thawing Time of Biologics During Large Scale Freeze-Thawing Cycles

(M1430-09-57) Using Enzymes to Accelerate PS80 Degradation and Elucidate Mechanistic Impacts of PS80 Degradants on Protein Stability via Thermal- and Agitation-Induced Aggregation

(T1530-08-49) Capillary Mediated Vitrification (CMV) is a User-Friendly Alternative to Lyophilization for the Production of Thermostable Bio-molecules

(T1530-08-53) The Effects of Aberrant Trisulfide Bond Formation in Therapeutic Proteins for Product Quality and Comparative Analytical Assessments

(T1530-09-56) Points to Consider in the Development of Activity and Potency Assays for Enzyme Biotherapeutics

(M1530-09-57) Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles

(M1530-09-58) Critical Manufacturing Parameters and Their Impacts on the Product Attributes of Bupivacaine Multivesicular Liposomal Formulation (Exparel^®)

(T1130-08-50) Highly Protein-Loaded Melt Extrudates Produced by Small-Scale Ram and Twin-Screw Extrusion - Evaluation of Extrusion Process Design on Protein Integrity by Experimental and Numerical Approaches

(W0930-08-49) Study and Characterization of Polyurethane Mixtures to be Employed in Direct Powder Extrusion Using Expert Systems

(M0930-08-50) Design, Development, and Evaluation of Novel Extended-Release Liposomal Topical Cream Formulation of Pregabalin Using Microemulsion Technique for the Treatment of Local Neuropathic Pain

(W0930-08-50) Impact of Hot Melt Extrusion Processing on Amorphous Solid Dispersion Bulk Powder Properties

(W0930-08-51) Linking 3DP Manufacturing with SIFT-MS Volatiles Organic Compound Analysis

(M0930-08-51) Peak Shear and the Effect of Kneading Block Geometries on Twin Screw Granulation Process Design

(W0930-08-52) Method Development for the Evaluation of Orally Inhaled Drug Products (OIDPs) containing Spray-Dried Phospholipid Porous Particles (PPPs)

(M0930-08-53) Advancements in Mini-Tablets: High Drug Loading and Precise Dose Titration

(W0930-08-53) Assessment of Laser Directed Infrared Imaging for In Vitro Characterization of Pharmaceutical Tablets

(W0930-08-54) Synchrotron X-Ray Diffraction of the Structure of Amorphous Indomethacin Using PDF Analysis and EPSR Modeling

(M0930-08-54) Use of Granulation and E-Tongue for Taste-Masking of an Orally Disintegrating Tablet (ODT)

(W0930-08-55) Distributed Manufacturing of 3D Printed Pharmaceuticals: A Case Study

(M0930-08-55) Worsened Punch Sticking by External Lubrication with Magnesium Stearate